The present disclosure generally relates to implantable medical devices, and more particularly, to implantable medical devices that are configured to be deployed across the atrioventricular septum.
Implantable medical devices are commonly used today to monitor a patient and/or deliver therapy to a patient. For example, implantable sensors are often used to monitor one or more physiological parameters of a patient, such as heart beats, heart sounds, ECG, respiration, etc. In some instances, pacing devices are used to treat patients suffering from various heart conditions that may result in a reduced ability of the heart to deliver sufficient amounts of blood to a patient's body. Such heart conditions may lead to slow, rapid, irregular, and/or inefficient heart contractions. To help alleviate some of these conditions, various medical devices (e.g., pacemakers, defibrillators, etc.) can be implanted in a patient's body. Such devices may monitor and in some cases provide electrical stimulation to the heart to help the heart operate in a more normal, efficient and/or safe manner. In some instances, it may be beneficial to sense and/or pace two or more chambers of the heart.
This disclosure provides design, delivery and deployment method, and clinical usage alternatives for medical devices. An example implantable medical device (IMD) configured for deployment at a patient's atrioventricular septum in order to sense and/or pace a patient's heart is disclosed, the atrioventricular septum of the patient's heart having an atrial facing side defining part of the right atrium of the patient's heart and a ventricle facing side defining part of the left ventricle of the patient's heart. The IMD includes a first component that is configured to be positioned at least in part in the right atrium of the patient's heart proximate the atrioventricular septum once the IMD is implanted and that includes a housing, a power source disposed within the housing and circuitry disposed within the housing and operably coupled to the power source. The IMD includes a second component that is configured to be positioned at least in part in the left ventricle of the patient's heart once the IMD is implanted and that is mechanically coupled to the first component through a passage passing through the atrioventricular septum. The second component includes a housing and two or more electrodes for sensing and/or pacing the left ventricle of the patient's heart.
Alternatively or additionally to any of the embodiments above, the first component further includes two or more electrodes for sensing and/or pacing the right atrium of the patient's heart.
Alternatively or additionally to any of the embodiments above, the two or more electrodes of the second component are operably coupled to the circuitry of the first component.
Alternatively or additionally to any of the embodiments above, at least one of the two or more electrodes of the second component engage the ventricle facing side of the atrioventricular septum of the patient's heart once the IMD is implanted.
Alternatively or additionally to any of the embodiments above, at least one of the two or more electrodes of the first component engage the atrial facing side of the atrioventricular septum of the patient's heart once the IMD is implanted.
Alternatively or additionally to any of the embodiments above, the second component is configured to move from a contracted state to an expanded state, wherein during implantation of the IMD, the second component is configured to pass through the passage through the atrioventricular septum in the contracted state and then move to the expanded state once in the left ventricle of the patient's heart.
Alternatively or additionally to any of the embodiments above, wherein in the expanded state, the second component extends laterally beyond a lateral extent of the passage through the atrioventricular septum and engages the ventricle facing side of the atrioventricular septum of the patient's heart.
Alternatively or additionally to any of the embodiments above, the first component extends distally beyond a delivery catheter and engages the atrial facing side of the atrioventricular septum of the patient's heart once the IMD is implanted.
Alternatively or additionally to any of the embodiments above, the second component is configured to cut the passage through the atrioventricular septum while the IMD is implanted.
Alternatively or additionally to any of the embodiments above, the second component is mechanically coupled to the first component through the passage via a connecting member.
Alternatively or additionally to any of the embodiments above, the connecting member is part of the second component, and forms an interference fit with the first component.
Alternatively or additionally to any of the embodiments above, the connecting member is part of the first component, and forms an interference fit with the first component.
Alternatively or additionally to any of the embodiments above, the first component comprises a fixation element for securing the first component to the atrioventricular septum of the patient's heart.
Alternatively or additionally to any of the embodiments above, the second component comprises a fixation element for securing the second component to the atrioventricular septum of the patient's heart.
An implantable medical device (IMD) configured for deployment at a patient's atrioventricular septum is disclosed, the atrioventricular septum of the patient's heart having an atrial facing side defining part of the right atrium of the patient's heart and a ventricle facing side defining part of the left ventricle of the patient's heart. The IMD includes a body having a first end portion, a second end portion and a connecting portion connecting the first end portion to the second end portion. At least part of the first end portion may be configured to be positioned in the right atrium of the patient's heart proximate the atrioventricular septum once the IMD is implanted and at least part of the second end portion extends into the left ventricle of the patient's heart once the IMD is implanted. The connecting portion extends through a passage that passes through the atrioventricular septum and the second end portion extends laterally beyond a lateral extent of the connecting portion to engage the ventricle facing side of the atrioventricular septum of the patient's heart once the IMD is implanted.
Alternatively or additionally to any of the embodiments above, the second end portion includes two or more electrodes for sensing and/or pacing the left ventricle of the patient's heart, wherein at least one of the two or more electrodes of the second end portion engages the ventricle facing side of the atrioventricular septum of the patient's heart.
Alternatively or additionally to any of the embodiments above, the first end portion includes two or more electrodes for sensing and/or pacing the right atrium of the patient's heart, wherein at least one of the two or more electrodes of the first end portion engages the atrial facing side of the atrioventricular septum of the patient's heart.
Alternatively or additionally to any of the embodiments above, at least part of the second end portion is configured to move from a contracted state to an expanded state.
A method of deploying a leadless pacing and sensing assembly proximate a patient's atrioventricular septum is disclosed, the leadless pacing and sensing assembly including a right atrial leadless cardiac pacemaker (LCP) and a left ventricular leadless cardiac pacemaker (LCP). The method includes advancing a delivery catheter through the patient's vasculature until a distal end of the delivery catheter is proximate an atrial side of the atrioventricular septum, the right atrial LCP disposed within a distal region of the delivery catheter. A deployment device is advanced past the right atrial LCP and through the atrioventricular septum, the left ventricular LCP secured to the deployment device such that the left ventricular LCP passes past the right atrial LCP and is disposed proximate a ventricular side of the atrioventricular septum. The left ventricular LCP is secured to the right atrial LCP and the deployment device is withdrawn.
Alternatively or additionally to any of the embodiments above, the method further comprises withdrawing the delivery catheter.
The above summary is not intended to describe each embodiment or every implementation of the present disclosure. Advantages and attainments, together with a more complete understanding of the disclosure, will become apparent and appreciated by referring to the following description and claims taken in conjunction with the accompanying drawings.
The disclosure may be more completely understood in consideration of the following description of various illustrative embodiments in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular illustrative embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
The following description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The description and the drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.
All numbers are herein assumed to be modified by the term “about”, unless the content clearly dictates otherwise. The recitation of numerical ranges by endpoints includes all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include the plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it is contemplated that the feature, structure, or characteristic may be applied to other embodiments whether or not explicitly described unless clearly stated to the contrary.
The present disclosure generally relates to implantable medical devices, and more particularly, to implantable medical devices that are configured to be deployed across the atrioventricular septum. More particularly, the present disclosure is directed at providing pacing and/or sensing from a position next to or within the atrioventricular septum. In order to call out particular features of the cardiac anatomy,
It will be appreciated that by traversing the AV septum 12 at or near the position indicated by the arrow 14, which is above the tricuspid valve TV and below the mitral valve MV, the left ventricle LV is accessible from the right atrium RA. This area can be reached, for example, via a transvenous catheter passing through either the SVC (superior vena cava) or the IVC (inferior vena cava) and into the right atrium RA. It will be appreciated that by deploying a two-part or multi-part LCP within the AV septum 12, it is possible to reach the left ventricle LV without having to potentially interfere with the mitral valve MV.
In some cases, the left seed 24 may be secured to a deployment mechanism 28 that can be used to advance the left seed 24 axially. The left seed 24 and the deployment mechanism 28 may be deployed within a hypotube 30 that may be configured to extend through the atrioventricular septum 12 (
Once deployed, the left seed 24 may be disposed at least partially on the ventricular side 18 of the AV septum 12, and the right seed 22 may be disposed at least partially on the atrial side 16 of the AV septum 12 (
In some cases, the central lumen 34 may also include one or more fixation elements (not explicitly shown) that are configured to engage with the left seed 24 and secure the left seed 24 to the right seed 22 once the left seed 24 has been deployed. The one or more fixation elements may, for example, extend to form a frictional engagement with the left seed 24. In some cases, the one or more fixation elements may be stent-like, and may expand to engage the left seed 24. In some instances, the one or more fixation elements may be formed of a shape memory material that can have a delivery shape that permits the left seed 24 to pass through the central lumen 34 of the right seed 22 and then revert to a “remembered” shape that engages the left seed 24 once the one or more fixation elements reach a particular temperature, for example. The one or more fixation elements could be formed from any of a variety of shape memory polymers or metals. In some cases, the one or more fixation elements may be formed of a nickel-titanium alloy such as Nitinol.
The right seed 22 includes, as illustrated, a first electrode 40 and a second electrode 42 that may be electrically coupled to internal circuitry within the right seed 22. While two electrodes 40, 42 are illustrated, it will be appreciated that the right seed 22 may include additional electrodes, depending on the desired pacing and/or sensing capabilities. In some cases, the first electrode 40 and the second electrode 42 may be disposed on the distal side of the right seed 22 such that both the first electrode 40 and the second electrode 42 may be in contact with the atrial side 16 of the AV septum 12 once implanted.
Once implanted, it will be appreciated that the connecting portion 58 will extend through a passage that passes across the AV septum 12. In some cases, the passage may be formed directly by the second end portion 56 being forced through the AV septum 12. In some instances, the passage may be formed by a separate needle, hypotube or other suitable device prior to inserting the second end portion 56. The second end portion 56 may extend laterally (e.g. lateral relative to the major axis of the connecting portion 58) beyond a lateral extent of the connecting portion 58 in order to engage the ventricle side 18 (
In some cases, as illustrated, the second end portion 56 may include electrodes for sensing and/or pacing the left ventricle LV. In some cases, the second end portion 56 may include a first electrode 60 and a second electrode 62 that are positioned on the second end portion 56 such that the first electrode 60 and the second electrode 62 are able to engage the ventricle side 18 of the AV septum 12. In some instances, the second end portion 56 may also include additional electrodes, but this is not required. In some cases, the first end portion 54 may include electrodes for sensing and/or pacing the right atrium RA. In some cases, the first end portion 54 may include a first electrode 64 and a second electrode 66 that are positioned on the first end portion 54 such that the first electrode 64 and the second electrode 66 are able to engage the atrial side 16 of the AV septum 12. In some instances, the first end portion 54 may also include additional electrodes, but this is not required.
The second component 74 may be mechanically coupled to the first component 72 through a passage passing through the AV septum 12. In some cases, the second component 74 is mechanically coupled to the first component 72 via a connecting member 82. In some cases, the connecting member 82 may be part of the second component 74 and may form an interference fit with the first component 72. In some cases, the connecting member 82 may be part of the first component 72 and may form an interference fit with the second component 74. In some cases, the first component 72 includes a fixation element for securing the first component 72 to the AV septum 12. In some instances, the second component 74 includes a fixation element for securing the second component 74 to the AV septum 12. Subsequent drawings will provides examples of such fixation elements, which may include one or more of barbs, spikes, pins, staples, threads, screws, helix, tines, and/or the like.
In some cases, the second component 74 may include a housing 84. The housing 84 may be a cylindrical body, for example. In some cases, the housing 84 may instead have another shape, or may simply be several insulated wires coupled together and including electrodes that are electrically coupled to the insulated wires, for example. In some instances, the housing 84 could be umbrella-shaped, with electrodes disposed at the tips of wires that may be joined together in a web. A first electrode 86 and a second electrode 88 may be disposed on the housing 84 and may be positioned such that the first electrode 86 and the second electrode 88 may be able to sense and/or pace the left ventricle LV of the heart. In some cases, the first electrode 86 and the second electrode 88 are configured to engage the ventricle side 18 (
In some cases, the first component 72 may include electrodes for sensing and/or pacing the right atrium RA. As illustrated, the first component 72 includes a first electrode 94 and a second electrode 96. In some cases, at least one of the first electrode 94 and the second electrode 96 may be positioned to engage the atrial side 16 (
In some instances, the second component 74 may be configured to move from a contracted state to an expanded state. In some cases, the second component 74 may pass through the passage formed in the AV septum 12 while in its contracted state and then move into its expanded state once the second component 74 has reached the left ventricle LV. In some cases, when in its expanded state, the second component 74 may extend laterally beyond a lateral extent of the passage through the AV septum 12 and may engage the ventricle side 18 (
In some cases, as illustrated, the LCP 100 may include a passage 122 that passes through the LCP 100 from a first side 124 of the housing 120 to a second side 126 of the housing 120. In some cases, the passage 122 is configured to allow the left seed 24 (
The electrodes 114 may be secured relative to the housing 120 but may be exposed to the tissue and/or blood surrounding the LCP 100. The electrodes 114 may generally conduct electrical signals to and from the LCP 100 and the surrounding tissue and/or blood. Such electrical signals can include communication pulses, electrical stimulation pulses, and intrinsic cardiac electrical signals. Intrinsic cardiac electrical signals may include electrical signals generated by the heart and may be represented by an electrocardiogram (ECG). The electrodes 114 can be made up of one or more biocompatible conductive materials such as various metals or alloys that are known to be safe for implantation within a human body. In some instances, the electrodes 114 may be generally disposed on either side of LCP 100 and may be in electrical communication with one or more of modules 102, 104, 106, 108, and 110. In examples where the electrodes 114 are secured directly to the housing 120, the electrodes 114 may have an insulative portion that electrically isolates the electrodes 114 from adjacent electrodes, the housing 120, and/or other portions of the LCP 100. Some or all of the electrodes 114 may be spaced from the housing 120 and connected to the housing 120 and/or other components of the LCP 100 through connecting wires or the like.
The electrodes 114 and/or 114′ may have any of a variety of sizes and/or shapes, and may be spaced at any suitable distance. For example, the electrodes 114 may have a diameter of one to five millimeters (mm). However, in other examples, the electrodes 114 and/or 114′ may have a diameter of one mm, two mm, three mm, or any other suitable diameter, dimension and shape. Example lengths for the electrodes 114 and/or 114′ include a length of one mm, three mm, five mm, or any other suitable length. Additionally, at least some of the electrodes 114 and/or 114′ may be spaced from one another by a distance of five mm, six mm, seven mm, or any other suitable distance. The electrodes 114 and/or 114′ of a single device may have different sizes with respect to each other, and the spacing of the electrodes on the device may or may not be uniform. In some cases, the electrode 114 may be a cathode with a smaller electrode surface area and the electrode 114′ may be an anode electrode with a larger electrode surface.
The communication module 102 may be electrically coupled to the electrodes 114 and/or 114′ and configured to deliver communication pulses to tissues of the patient for communicating with other devices such as sensors, programmers, other medical devices, and the like. Communication pulses, as used herein, may be any modulated signal that conveys information to another device, either by itself or in conjunction with one or more other modulated signals. In some examples, communication pulses are sub-threshold signals which convey information, but this is not required. Other devices that the communication module 102 may be configured to communicate with may be located either external or internal to the patient's body. The communication module 102 may additionally be configured to sense for communication pulses delivered by the other devices, which are located externally to the LCP 100. Irrespective of the location, the LCP 100 and the other devices may communicate with each other via the communication module 102 to accomplish one or more desired functions. Some example functions include storing communicated data, using communicated data for determining occurrences of arrhythmias, coordinating delivery of electrical stimulation therapy, and/or other functions.
The LCP 100 and the other devices may use the delivered communication pulses to communicate raw information, processed information, messages, and/or other data. Raw information may include information such as sensed electrical signals (e.g. a sensed ECG), signals gathered from coupled sensors, and the like. In some examples, the raw information may include signals that have been filtered using one or more signal processing techniques. Processed information may include any information that has been determined by the LCP 100. For example, processed information may include a determined heart rate, timings of determined heartbeats, timings of other determined events, determinations of threshold crossings, expirations of monitored time periods, and determined parameters such as activity parameters, blood-oxygen parameters, blood pressure parameters, heart sound parameters, and the like. Messages may include instructions directing another device to take action, notifications of imminent actions of the sending device, requests for reading from the receiving device or writing data to the receiving device. In some cases, the LCP 100 may communicate with an S-ICD (subcutaneous implantable cardioinverter).
In at least some examples, the communication module 102 (or the LCP 100) may further include switching circuitry to selectively connect one or more of the electrodes 114 and/or 114′ to the communication module 102 in order to select via which electrodes 114 and/or 114′ the communication module 102 delivers the communication pulses. Additionally, the communication module 102 may be configured to use one or more methods for communicating with other devices. For example, the communication module 102 may communicate via conducted signals, radiofrequency (RF) signals, optical signals, acoustic signals, inductive coupling, and/or any other signals or methods suitable for communication with an external device such as an S-ICD or a programmer.
The pulse generator module 104 of the LCP 100 may also be electrically connected to one or more of the electrodes 114 and/or 114′. The pulse generator module 104 may be configured to generate electrical stimulation pulses and deliver the electrical stimulation pulses to tissues of a patient via the electrodes 114 and/or 114′ electrodes in order to effectuate one or more electrical stimulation therapies. Electrical stimulation pulses as used herein are meant to encompass any electrical signals that may be delivered to tissue of a patient for purposes of treatment of any type of disease or abnormality. When used to treat heart diseases or abnormalities, the electrical stimulation pulses may generally be configured so as to capture the heart of the patient—cause the heart to contract in response to the delivered electrical stimulation pulse. In at least examples where the pulse generator 104 is configured to generate specific types of electrical stimulation pulses termed defibrillation/cardioversion pulses, the pulse generator module 104 may include one or more capacitor elements.
The pulse generator module 104 may include capability to modify the electrical stimulation pulses, such as by adjusting a pulse width or amplitude of the electrical stimulation pulses, in order to ensure that the delivered electrical stimulation pulses consistently capture the heart. The pulse generator module 104 may use energy stored in the energy storage module 112 to generate the electrical stimulation pulses. In at least some examples, the pulse generator module 104 (or the LCP 100) may further include switching circuitry to selectively connect one or more of the electrodes 114 and/or 114′ to the pulse generator module 104 in order to select via which electrodes 114 and/or 114′ the pulse generator 104 delivers the electrical stimulation pulses.
In some examples, the LCP 100 may include the electrical sensing module 106 and the mechanical sensing module 108. The electrical sensing module 106 may be configured to sense intrinsic cardiac electrical signals conducted from the electrodes 114 and/or 114′ to the electrical sensing module 106. For example, the electrical sensing module 106 may be electrically connected to one or more electrodes 114 and/or 114′ and the electrical sensing module 106 may be configured to receive cardiac electrical signals conducted through the electrodes 114 and/or 114′. In some examples, the cardiac electrical signals may represent local information from the chamber in which the LCP 100 is implanted. For instance, if the LCP 100 is implanted within the right atrium RA, cardiac electrical signals sensed by the LCP 100 through the electrodes 114 and/or 114′ may represent atrial cardiac electrical signals. The mechanical sensing module 108 may include, or be electrically connected to, various sensors, such as accelerometers, blood pressure sensors, heart sound sensors, blood-oxygen sensors, and/or other sensors which measure one or more physiological parameters of the heart and/or patient. The mechanical sensing module 108 may gather signals from the sensors indicative of the various physiological parameters. Both the electrical sensing module 106 and the mechanical sensing module 108 may be further connected to the processing module 110 and may provide signals representative of the sensed cardiac electrical signals and/or physiological signals to processing the module 110. Although described with respect to
The processing module 110 may be configured to control the operation of the LCP 100. For example, the processing module 110 may be configured to receive cardiac electrical signals from the electrical sensing module 106 and/or physiological signals from the mechanical sensing module 108. Based on the received signals, the processing module 110 may determine occurrences and types of arrhythmias. The processing module 110 may further receive information from the communication module 102. In some examples, the processing module 110 may additionally use such received information to determine occurrences and types of arrhythmias. However, in other examples, the LCP 100 may use the received information instead of the signals received from the electrical sensing module 106 and/or the mechanical sensing module 108—for instance if the received information is more accurate than the signals received from the electrical sensing module 106 and/or the mechanical sensing module 108 or if the electrical sensing module 106 and/or the mechanical sensing module 108 have been disabled or omitted from the LCP 100.
Based on any determined arrhythmias, the processing module 110 may then control the pulse generator module 104 to generate electrical stimulation pulses in accordance with one or more electrical stimulation therapies to treat the determined arrhythmias. For example, the processing module 110 may control the pulse generator module 104 to generate pacing pulses with varying parameters and in different sequences to effectuate one or more electrical stimulation therapies. In controlling the pulse generator module 104 to deliver bradycardia pacing therapy, the processing module 110 may control the pulse generator module 104 to deliver pacing pulses designed to capture the heart of the patient at a regular interval to prevent the heart of a patient from falling below a predetermined threshold. For ATP therapy, the processing module 110 may control the pulse generator module 104 to deliver pacing pulses at a rate faster than an intrinsic heart rate of a patient in attempt to force the heart to beat in response to the delivered pacing pulses rather than in response to intrinsic cardiac electrical signals. The processing module 110 may then control the pulse generator module 104 to reduce the rate of delivered pacing pulses down to a safe level. In CRT, the processing module 110 may control the pulse generator module 104 to deliver pacing pulses in coordination with another device (e.g. the left seed 24) to cause the heart to contract more efficiently. Additionally, in cases where the pulse generator module 104 is capable of generating defibrillation and/or cardioversion pulses for defibrillation/cardioversion therapy, the processing module 110 may control the pulse generator module 104 to generate such defibrillation and/or cardioversion pulses. In some examples, the LCO 100 may instead communicate with an S-ICD for defibrillation therapy. In other examples, the processing module 110 may control the pulse generator module 104 to generate electrical stimulation pulses to provide electrical stimulation therapies different than those described herein to treat one or more detected cardiac arrhythmias.
Aside from controlling the pulse generator module 104 to generate different types of electrical stimulation pulses and in different sequences, in some examples, the processing module 110 may also control the pulse generator module 104 to generate the various electrical stimulation pulses with varying pulse parameters. For example, each electrical stimulation pulse may have a pulse width and a pulse amplitude. The processing module 110 may control the pulse generator module 104 to generate the various electrical stimulation pulses with specific pulse widths and pulse amplitudes. For example, the processing module 110 may cause the pulse generator module 104 to adjust the pulse width and/or the pulse amplitude of electrical stimulation pulses if the electrical stimulation pulses are not effectively capturing the heart. Such control of the specific parameters of the various electrical stimulation pulses may ensure that the LCP 100 is able to provide effective delivery of electrical stimulation therapy.
In some examples, the processing module 110 may further control the communication module 102 to send information to other devices. For example, the processing module 110 may control the communication module 102 to generate one or more communication pulses for communicating with other devices of a system of devices. For instance, the processing module 110 may control the communication module 102 to generate communication pulses in particular sequences, where the specific sequences convey different data to other devices. The communication module 102 may also conduct any received communication signals to the processing module 110 for potential action by the processing module 110.
In further examples, the processing module 110 may additionally control switching circuitry by which the communication module 102 and the pulse generator module 104 deliver communication pulses and electrical stimulation pulses to tissue of the patient. As described above, both the communication module 102 and the pulse generator module 104 may include circuitry for connecting one or more electrodes 114 and/114′ to the communication module 102 and the pulse generator module 104 so those modules may deliver the communication pulses and electrical stimulation pulses to tissue of the patient. The specific combination of one or more electrodes by which the communication module 102 and the pulse generator module 104 deliver communication pulses and electrical stimulation pulses influence the reception of communication pulses and/or the effectiveness of electrical stimulation pulses. Although it was described that each of the communication module 102 and the pulse generator module 104 may include switching circuitry, in some examples the LCP 100 may have a single switching module connected to all of the communication module 102, the pulse generator module 104, and the electrodes 114 and/or 114′. In such examples, the processing module 110 may control the single switching module to connect the modules 102/104 and the electrodes 114/114′.
In still additional examples, the processing module 110 may control the pulse generator module 104 to generate the communication pulses for communicating with external devices. In such examples, the communication module 102 may not include the capability to generate communication pulses. In some even additional examples, the electrical sensing module 106 may further include the capability to sense communication pulses. In such examples, the electrical sensing module 106 may communicate any received communication pulses to the processing module 110. In such examples, the LCP 100 may not include the communication module 102, as the functions of the communication module 102 are subsumed within the pulse generator module 104 and the electrical sensing module 106. However, in such examples, the LCP 100 may not be able to simultaneously generate both communication pulses and electrical stimulation pulses.
In some examples, the processing module 110 may include a pre-programmed chip, such as a very-large-scale integration (VLSI) chip or an application specific integrated circuit (ASIC). In such embodiments, the chip may be pre-programmed with control logic in order to control the operation of the LCP 100. By using a pre-programmed chip, the processing module 110 may use less power than other programmable circuits while able to maintain basic functionality, thereby increasing the battery life of the LCP 100. In other examples, the processing module 110 may include a programmable microprocessor or the like. Such a programmable microprocessor may allow a user to adjust the control logic of the LCP 100 after manufacture, thereby allowing for greater flexibility of the LCP 100 than when using a pre-programmed chip.
The processing module 110, in additional examples, may further include a memory circuit and the processing module 110 may store information on and read information from the memory circuit. In other examples, the LCP 100 may include a separate memory circuit (not shown) that is in communication with the processing module 110, such that the processing module 110 may read and write information to and from the separate memory circuit. The memory circuit, whether part of the processing module 110 or separate from the processing module 110 may have address lengths of, for example, eight bits. However, in other examples, the memory circuit may have address lengths of sixteen, thirty-two, or sixty-four bits, or any other bit length that is suitable. Additionally, the memory circuit may be volatile memory, non-volatile memory, or a combination of both volatile memory and non-volatile memory.
The energy storage module 112 may provide a power source to the LCP 100 for its operations. In some examples, the energy storage module 112 may be a non-rechargeable lithium-based battery. In other examples, the non-rechargeable battery may be made from other suitable materials known in the art. Because the LCP 100 is an implantable device, access to the LCP 100 may be limited. In such circumstances, it is necessary to have sufficient energy capacity to deliver therapy over an extended period of treatment such as days, weeks, months, or years. In some examples, the energy storage module 112 may a rechargeable battery in order to facilitate increasing the useable lifespan of the LCP 100. In still other examples, the energy storage module 112 may be other types of energy storage devices such as capacitors.
In some cases, the LCP 200 may include a communication module 202, a pulse generator module 204, an electrical sensing module 206, a mechanical sensing module 208, a processing module 210, and a battery 218. Each of these modules may be similar to the modules 102, 104, 106, 108, and 110 of the LCP 100. Additionally, the battery 218 may be similar to the battery 112 of the LCP 100. In some cases, the LCP 200 may include leads such as leads 212. The leads 212 may include electrical wires that conduct electrical signals between the electrodes 214 and one or more of the modules located within housing 220. In some cases, the leads 212 may be connected to and extend away from the housing 220 of the LCP 200 in order to place electrodes 214 adjacent the atrial side 16 and/or the ventricle side 18 of the AV septum 12.
The mechanical sensing module 208, as with the mechanical sensing module 108, may contain or be electrically connected to one or more sensors, such as accelerometers, blood pressure sensors, heart sound sensors, blood-oxygen sensors, and/or other sensors which are configured to measure one or more mechanical/chemical parameters of the heart and/or patient. In some examples, one or more of the sensors may be located on the leads 212, but this is not required. In some examples, one or more of the sensors may be located in the housing 220.
The distal tip 318 holds the first and second electrical conduits 310, 314 in the illustrated position for deployment. In some cases, the distal tip 318 is dissolvable upon exposure to blood. In some cases, the distal tip 318 may be formed of a crystallized material such as sugar that is safe for dissolving in the blood stream. Accordingly, the first and second electrical conduits 310, 314 may be held in a delivery configuration for delivery and subsequently may move into a deployment configuration (as shown for example in
In
The cylindrical body 408 may include a proximal end 411 that is slidingly disposed within a chamber 422 that is formed within the right seed 402. It will be appreciated that the chamber 422 includes a distal end 424 that is configured to limit axial travel of the proximal end 411 of the left seed 404. Accordingly, the interaction between the proximal end 411 of the left seed 404 and the distal end 424 of the chamber 422 of the right seed 402 limits how far the left seed 404 can extend into the left ventricle LV. Once the distal tip 418 has dissolved or otherwise disappeared, the first and second electrical conduits 410 and 414 move into position against the ventricle side 18 of the AV septum 12, thereby limiting movement of the left seed 404 back towards the right atrium RA. Thus, the left seed 404 is locked in position relative to the right seed 402 and relative to the AV septum 12. In some embodiments, the left seed 404 may include a membrane 450 that may help to secure between the left seed 404 and the ventricle side 18 of the AV septum 12. In some cases, the membrane 450 may be formed of a flexible material such as silicone, and may be impregnated with a salt or other material that will cause the membrane 450 to swell upon exposure to blood. In some instances, the membrane 450 may have a folded down configuration for deployment of the left seed 404 and may subsequently revert to the expanded configuration shown in
In the example shown, the cylindrical body 508 of the left seed 504 includes a ratchet section 530 that is configured to interact with a corresponding ratchet section 532 disposed within the passage 506 formed within the right seed 502. In order to implant the LCP 500, the LCP 500 may be delivered to the right atrium RA with the left seed 504 disposed within the right seed 502 as illustrated, i.e., with the ratchet section 530 positioned outside of the right seed 502. Alternatively, the left seed 504 may be delivered to the right atrium RA and then the right seed 502 may be advanced over the left seed 504.
Once the left seed 504 has been advanced through the AV septum 12, and the distal tip 518 has dissolved or otherwise disappeared, the electrical conduits 510 and 514 may move the electrodes 512 and 516, respectively, into position against the ventricle side 18 of the AV septum 12. The left seed 504 may then be pulled back through the right seed 502 such that the ratchet section 530 engages the ratchet section 532. The ratchet sections 530 and 532 may be configured to permit the ratchet section 530 to move right to left (in the illustrated orientation), relative to the ratchet section 532 but not permit the ratchet section 530 to move left to right relative to the ratchet section 532. It will be appreciated that
In some embodiments, the left seed 504 may include a membrane 550 that may help to secure between the left seed 504 and the ventricle side 18 of the AV septum 12 and prevent blood from moving towards the right atrium RA after removal of a deployment device. In some cases, the membrane 550 may be formed of a flexible material such as silicone, and may be impregnated with a salt or other material that will cause the membrane 550 to swell upon exposure to blood. In some instances, the membrane 550 may have a folded down configuration for deployment of the left seed 504 and may subsequently revert to the expanded configuration shown in
In some cases, the cylindrical body 608 of the left seed 604 may include a threaded portion 640 that threadedly engages a corresponding threaded portion 642 formed within the passage 606. Accordingly, advancement of the left seed 604 relative to the right seed 602 may be closely controlled. Once the left seed 604 has been deployed, the distal tip 618 may dissolve or otherwise disappear, and the first electrical conduit 610 and the second electrical conduit 614 may be able to move into a deployed configuration in which the first electrode 612 and the second electrode 616 are positioned against the ventricle side 18 of the AV septum 12. The left seed 604 may then be moved backward relative to the right seed 602 in order to lock the left seed 604 in place relative to the AV septum 12 and relative to the right seed 602 by rotating the left seed 604 in an opposite direction to that used to advance the left seed 604. In some cases, the threaded portion 642 may include a vinyl bump or other structure 644 that serves to lock the left seed 604 in position and not permit undesired movement after implantation.
In some embodiments, the left seed 604 may include a membrane 650 that may help to secure between the left seed 504 and the ventricle side 18 of the AV septum 12. In some cases, the membrane 550 may be formed of a flexible material such as silicone, and may be impregnated with a salt or other material that will cause the membrane 650 to swell upon exposure to blood. In some instances, the membrane 650 may have a folded down configuration for deployment of the left seed 604 and may subsequently revert to the expanded configuration shown in
Those skilled in the art will recognize that the present disclosure may be manifested in a variety of forms other than the specific examples described and contemplated herein. For instance, as described herein, various examples include one or more modules described as performing various functions. However, other examples may include additional modules that split the described functions up over more modules than that described herein. Additionally, other examples may consolidate the described functions into fewer modules. Accordingly, departure in form and detail may be made without departing from the scope and spirit of the present disclosure as described in the appended claims.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/271,647 filed on Dec. 28, 2015, the disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3835864 | Rasor et al. | Sep 1974 | A |
3943936 | Rasor et al. | Mar 1976 | A |
4142530 | Wittkampf | Mar 1979 | A |
4151513 | Menken et al. | Apr 1979 | A |
4157720 | Greatbatch | Jun 1979 | A |
RE30366 | Rasor et al. | Aug 1980 | E |
4243045 | Maas | Jan 1981 | A |
4250884 | Hartlaub et al. | Feb 1981 | A |
4256115 | Bilitch | Mar 1981 | A |
4263919 | Levin | Apr 1981 | A |
4310000 | Lindemans | Jan 1982 | A |
4312354 | Walters | Jan 1982 | A |
4323081 | Wiebusch | Apr 1982 | A |
4357946 | Dutcher et al. | Nov 1982 | A |
4365639 | Goldreyer | Dec 1982 | A |
4440173 | Hudziak et al. | Apr 1984 | A |
4476868 | Thompson | Oct 1984 | A |
4522208 | Buffet | Jun 1985 | A |
4537200 | Widrow | Aug 1985 | A |
4556063 | Thompson et al. | Dec 1985 | A |
4562841 | Brockway et al. | Jan 1986 | A |
4593702 | Kepski et al. | Jun 1986 | A |
4593955 | Leiber | Jun 1986 | A |
4630611 | King | Dec 1986 | A |
4635639 | Hakala et al. | Jan 1987 | A |
4674508 | DeCote | Jun 1987 | A |
4712554 | Garson | Dec 1987 | A |
4729376 | DeCote | Mar 1988 | A |
4754753 | King | Jul 1988 | A |
4759366 | Callaghan | Jul 1988 | A |
4776338 | Lekholm et al. | Oct 1988 | A |
4787389 | Tarjan | Nov 1988 | A |
4793353 | Borkan | Dec 1988 | A |
4819662 | Heil et al. | Apr 1989 | A |
4858610 | Callaghan et al. | Aug 1989 | A |
4886064 | Strandberg | Dec 1989 | A |
4887609 | Cole, Jr. | Dec 1989 | A |
4928688 | Mower | May 1990 | A |
4967746 | Vandegriff | Nov 1990 | A |
4987897 | Funke | Jan 1991 | A |
4989602 | Sholder et al. | Feb 1991 | A |
5012806 | De Bellis | May 1991 | A |
5036849 | Hauck et al. | Aug 1991 | A |
5040534 | Mann et al. | Aug 1991 | A |
5058581 | Silvian | Oct 1991 | A |
5078134 | Heilman et al. | Jan 1992 | A |
5109845 | Yuuchi et al. | May 1992 | A |
5113859 | Funke | May 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5117824 | Keimel et al. | Jun 1992 | A |
5127401 | Grevious et al. | Jul 1992 | A |
5133353 | Hauser | Jul 1992 | A |
5144950 | Stoop et al. | Sep 1992 | A |
5170784 | Ramon et al. | Dec 1992 | A |
5179945 | Van Hofwegen et al. | Jan 1993 | A |
5193539 | Schulman et al. | Mar 1993 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5241961 | Henry | Sep 1993 | A |
5243977 | Trabucco et al. | Sep 1993 | A |
5259387 | dePinto | Nov 1993 | A |
5269326 | Verrier | Dec 1993 | A |
5284136 | Hauck et al. | Feb 1994 | A |
5300107 | Stokes et al. | Apr 1994 | A |
5301677 | Hsung | Apr 1994 | A |
5305760 | McKown et al. | Apr 1994 | A |
5312439 | Loeb | May 1994 | A |
5313953 | Yomtov et al. | May 1994 | A |
5314459 | Swanson et al. | May 1994 | A |
5318597 | Hauck et al. | Jun 1994 | A |
5324316 | Schulman et al. | Jun 1994 | A |
5331966 | Bennett et al. | Jul 1994 | A |
5334222 | Salo et al. | Aug 1994 | A |
5342408 | Decoriolis et al. | Aug 1994 | A |
5370667 | Alt | Dec 1994 | A |
5372606 | Lang et al. | Dec 1994 | A |
5376106 | Stahmann et al. | Dec 1994 | A |
5383915 | Adams | Jan 1995 | A |
5388578 | Yomtov et al. | Feb 1995 | A |
5404877 | Nolan et al. | Apr 1995 | A |
5405367 | Schulman et al. | Apr 1995 | A |
5411031 | Yomtov | May 1995 | A |
5411525 | Swanson et al. | May 1995 | A |
5411535 | Fujii et al. | May 1995 | A |
5456691 | Snell | Oct 1995 | A |
5458622 | Alt | Oct 1995 | A |
5466246 | Silvian | Nov 1995 | A |
5468254 | Hahn et al. | Nov 1995 | A |
5472453 | Alt | Dec 1995 | A |
5522866 | Fernald | Jun 1996 | A |
5540727 | Tockman et al. | Jul 1996 | A |
5545186 | Olson et al. | Aug 1996 | A |
5545202 | Dahl et al. | Aug 1996 | A |
5571146 | Jones et al. | Nov 1996 | A |
5591214 | Lu | Jan 1997 | A |
5620466 | Haefner et al. | Apr 1997 | A |
5634938 | Swanson et al. | Jun 1997 | A |
5649968 | Alt et al. | Jul 1997 | A |
5662688 | Haefner et al. | Sep 1997 | A |
5674259 | Gray | Oct 1997 | A |
5683426 | Greenhut et al. | Nov 1997 | A |
5683432 | Goedeke et al. | Nov 1997 | A |
5706823 | Wodlinger | Jan 1998 | A |
5709215 | Perttu et al. | Jan 1998 | A |
5720770 | Nappholz et al. | Feb 1998 | A |
5728154 | Crossett et al. | Mar 1998 | A |
5741314 | Daly et al. | Apr 1998 | A |
5741315 | Lee et al. | Apr 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5752977 | Grevious et al. | May 1998 | A |
5755736 | Gillberg et al. | May 1998 | A |
5759199 | Snell et al. | Jun 1998 | A |
5774501 | Halpern et al. | Jun 1998 | A |
5792195 | Carlson et al. | Aug 1998 | A |
5792202 | Rueter | Aug 1998 | A |
5792203 | Schroeppel | Aug 1998 | A |
5792205 | Alt et al. | Aug 1998 | A |
5792208 | Gray | Aug 1998 | A |
5814089 | Stokes et al. | Sep 1998 | A |
5827216 | Igo et al. | Oct 1998 | A |
5836985 | Goyal et al. | Nov 1998 | A |
5836987 | Baumann et al. | Nov 1998 | A |
5842977 | Lesho et al. | Dec 1998 | A |
5855593 | Olson et al. | Jan 1999 | A |
5873894 | Vandegriff et al. | Feb 1999 | A |
5891184 | Lee et al. | Apr 1999 | A |
5897586 | Molina | Apr 1999 | A |
5899876 | Flower | May 1999 | A |
5899928 | Sholder et al. | May 1999 | A |
5919214 | Ciciarelli et al. | Jul 1999 | A |
5935078 | Feierbach | Aug 1999 | A |
5941906 | Barreras et al. | Aug 1999 | A |
5944744 | Paul et al. | Aug 1999 | A |
5954757 | Gray | Sep 1999 | A |
5978713 | Prutchi et al. | Nov 1999 | A |
5991660 | Goyal | Nov 1999 | A |
5991661 | Park et al. | Nov 1999 | A |
5999848 | Gord et al. | Dec 1999 | A |
5999857 | Weijand et al. | Dec 1999 | A |
6016445 | Baura | Jan 2000 | A |
6026320 | Carlson et al. | Feb 2000 | A |
6029085 | Olson et al. | Feb 2000 | A |
6041250 | dePinto | Mar 2000 | A |
6044298 | Salo et al. | Mar 2000 | A |
6044300 | Gray | Mar 2000 | A |
6055454 | Heemels | Apr 2000 | A |
6073050 | Griffith | Jun 2000 | A |
6076016 | Feierbach | Jun 2000 | A |
6077236 | Cunningham | Jun 2000 | A |
6080187 | Alt et al. | Jun 2000 | A |
6083248 | Thompson | Jul 2000 | A |
6106551 | Crossett et al. | Aug 2000 | A |
6115636 | Ryan | Sep 2000 | A |
6128526 | Stadler et al. | Oct 2000 | A |
6141581 | Olson et al. | Oct 2000 | A |
6141588 | Cox et al. | Oct 2000 | A |
6141592 | Pauly | Oct 2000 | A |
6144879 | Gray | Nov 2000 | A |
6162195 | Igo et al. | Dec 2000 | A |
6164284 | Schulman et al. | Dec 2000 | A |
6167310 | Grevious | Dec 2000 | A |
6201993 | Kruse et al. | Mar 2001 | B1 |
6208894 | Schulman et al. | Mar 2001 | B1 |
6211799 | Post et al. | Apr 2001 | B1 |
6221011 | Bardy | Apr 2001 | B1 |
6240316 | Richmond et al. | May 2001 | B1 |
6240317 | Villaseca et al. | May 2001 | B1 |
6256534 | Dahl | Jul 2001 | B1 |
6259947 | Olson et al. | Jul 2001 | B1 |
6266558 | Gozani et al. | Jul 2001 | B1 |
6266567 | Ishikawa et al. | Jul 2001 | B1 |
6270457 | Bardy | Aug 2001 | B1 |
6272377 | Sweeney et al. | Aug 2001 | B1 |
6273856 | Sun et al. | Aug 2001 | B1 |
6277072 | Bardy | Aug 2001 | B1 |
6280380 | Bardy | Aug 2001 | B1 |
6285907 | Kramer et al. | Sep 2001 | B1 |
6292698 | Duffin et al. | Sep 2001 | B1 |
6295473 | Rosar | Sep 2001 | B1 |
6297943 | Carson | Oct 2001 | B1 |
6298271 | Weijand | Oct 2001 | B1 |
6307751 | Bodony et al. | Oct 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6315721 | Schulman et al. | Nov 2001 | B2 |
6336903 | Bardy | Jan 2002 | B1 |
6345202 | Richmond et al. | Feb 2002 | B2 |
6351667 | Godie | Feb 2002 | B1 |
6351669 | Hartley et al. | Feb 2002 | B1 |
6353759 | Hartley et al. | Mar 2002 | B1 |
6358203 | Bardy | Mar 2002 | B2 |
6361780 | Ley et al. | Mar 2002 | B1 |
6368284 | Bardy | Apr 2002 | B1 |
6371922 | Baumann et al. | Apr 2002 | B1 |
6398728 | Bardy | Jun 2002 | B1 |
6400982 | Sweeney et al. | Jun 2002 | B2 |
6400990 | Silvian | Jun 2002 | B1 |
6408208 | Sun | Jun 2002 | B1 |
6409674 | Brockway et al. | Jun 2002 | B1 |
6411848 | Kramer et al. | Jun 2002 | B2 |
6424865 | Ding | Jul 2002 | B1 |
6434429 | Kraus et al. | Aug 2002 | B1 |
6438410 | Hsu et al. | Aug 2002 | B2 |
6438417 | Rockwell et al. | Aug 2002 | B1 |
6438421 | Stahmann et al. | Aug 2002 | B1 |
6440066 | Bardy | Aug 2002 | B1 |
6441747 | Khair et al. | Aug 2002 | B1 |
6442426 | Kroll | Aug 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6443891 | Grevious | Sep 2002 | B1 |
6445953 | Bulkes et al. | Sep 2002 | B1 |
6453200 | Koslar | Sep 2002 | B1 |
6459929 | Hopper et al. | Oct 2002 | B1 |
6470215 | Kraus et al. | Oct 2002 | B1 |
6471645 | Warkentin et al. | Oct 2002 | B1 |
6480745 | Nelson et al. | Nov 2002 | B2 |
6487443 | Olson et al. | Nov 2002 | B2 |
6490487 | Kraus et al. | Dec 2002 | B1 |
6498951 | Larson et al. | Dec 2002 | B1 |
6507755 | Gozani et al. | Jan 2003 | B1 |
6507759 | Prutchi et al. | Jan 2003 | B1 |
6512940 | Brabec et al. | Jan 2003 | B1 |
6522915 | Ceballos et al. | Feb 2003 | B1 |
6526311 | Begemann | Feb 2003 | B2 |
6539253 | Thompson et al. | Mar 2003 | B2 |
6542775 | Ding et al. | Apr 2003 | B2 |
6553258 | Stahmann et al. | Apr 2003 | B2 |
6561975 | Pool et al. | May 2003 | B1 |
6564807 | Schulman et al. | May 2003 | B1 |
6574506 | Kramer et al. | Jun 2003 | B2 |
6584351 | Ekwall | Jun 2003 | B1 |
6584352 | Combs et al. | Jun 2003 | B2 |
6597948 | Rockwell et al. | Jul 2003 | B1 |
6597951 | Kramer et al. | Jul 2003 | B2 |
6622046 | Fraley et al. | Sep 2003 | B2 |
6628985 | Sweeney et al. | Sep 2003 | B2 |
6647292 | Bardy et al. | Nov 2003 | B1 |
6666844 | Igo et al. | Dec 2003 | B1 |
6689117 | Sweeney et al. | Feb 2004 | B2 |
6690959 | Thompson | Feb 2004 | B2 |
6694189 | Begemann | Feb 2004 | B2 |
6704602 | Berg et al. | Mar 2004 | B2 |
6718212 | Parry et al. | Apr 2004 | B2 |
6721597 | Bardy et al. | Apr 2004 | B1 |
6738670 | Almendinger et al. | May 2004 | B1 |
6746797 | Benson et al. | Jun 2004 | B2 |
6749566 | Russ | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6763269 | Cox | Jul 2004 | B2 |
6778860 | Ostroff et al. | Aug 2004 | B2 |
6788971 | Sloman et al. | Sep 2004 | B1 |
6788974 | Bardy et al. | Sep 2004 | B2 |
6804558 | Haller et al. | Oct 2004 | B2 |
6807442 | Myklebust et al. | Oct 2004 | B1 |
6847844 | Sun et al. | Jan 2005 | B2 |
6871095 | Stahmann et al. | Mar 2005 | B2 |
6878112 | Linberg et al. | Apr 2005 | B2 |
6885889 | Chinchoy | Apr 2005 | B2 |
6892094 | Ousdigian et al. | May 2005 | B2 |
6897788 | Khair et al. | May 2005 | B2 |
6904315 | Panken et al. | Jun 2005 | B2 |
6922592 | Thompson et al. | Jul 2005 | B2 |
6931282 | Esler | Aug 2005 | B2 |
6934585 | Schloss et al. | Aug 2005 | B1 |
6957107 | Rogers et al. | Oct 2005 | B2 |
6978176 | Lattouf | Dec 2005 | B2 |
6985773 | Von Arx et al. | Jan 2006 | B2 |
6990375 | Kloss et al. | Jan 2006 | B2 |
7001366 | Ballard | Feb 2006 | B2 |
7003350 | Denker et al. | Feb 2006 | B2 |
7006864 | Echt et al. | Feb 2006 | B2 |
7013178 | Reinke et al. | Mar 2006 | B2 |
7027871 | Burnes et al. | Apr 2006 | B2 |
7050849 | Echt et al. | May 2006 | B2 |
7060031 | Webb et al. | Jun 2006 | B2 |
7063693 | Guenst | Jun 2006 | B2 |
7082336 | Ransbury et al. | Jul 2006 | B2 |
7085606 | Flach et al. | Aug 2006 | B2 |
7092758 | Sun et al. | Aug 2006 | B2 |
7110824 | Amundson et al. | Sep 2006 | B2 |
7120504 | Osypka | Oct 2006 | B2 |
7130681 | Gebhardt et al. | Oct 2006 | B2 |
7139613 | Reinke et al. | Nov 2006 | B2 |
7142912 | Wagner et al. | Nov 2006 | B2 |
7146225 | Guenst et al. | Dec 2006 | B2 |
7146226 | Lau et al. | Dec 2006 | B2 |
7149581 | Goedeke | Dec 2006 | B2 |
7149588 | Lau et al. | Dec 2006 | B2 |
7158839 | Lau | Jan 2007 | B2 |
7162307 | Patrias | Jan 2007 | B2 |
7164952 | Lau et al. | Jan 2007 | B2 |
7177700 | Cox | Feb 2007 | B1 |
7181505 | Haller et al. | Feb 2007 | B2 |
7184830 | Echt et al. | Feb 2007 | B2 |
7186214 | Ness | Mar 2007 | B2 |
7191015 | Lamson et al. | Mar 2007 | B2 |
7200437 | Nabutovsky et al. | Apr 2007 | B1 |
7200439 | Zdeblick et al. | Apr 2007 | B2 |
7206423 | Feng et al. | Apr 2007 | B1 |
7209785 | Kim et al. | Apr 2007 | B2 |
7209790 | Thompson et al. | Apr 2007 | B2 |
7211884 | Davis et al. | May 2007 | B1 |
7212871 | Morgan | May 2007 | B1 |
7226440 | Gelfand et al. | Jun 2007 | B2 |
7228183 | Sun et al. | Jun 2007 | B2 |
7236821 | Cates et al. | Jun 2007 | B2 |
7236829 | Farazi et al. | Jun 2007 | B1 |
7254448 | Almendinger et al. | Aug 2007 | B2 |
7260436 | Kilgore et al. | Aug 2007 | B2 |
7270669 | Sra | Sep 2007 | B1 |
7272448 | Morgan et al. | Sep 2007 | B1 |
7277755 | Falkenberg et al. | Oct 2007 | B1 |
7280872 | Mosesov et al. | Oct 2007 | B1 |
7288096 | Chin | Oct 2007 | B2 |
7289847 | Gill et al. | Oct 2007 | B1 |
7289852 | Helfinstine et al. | Oct 2007 | B2 |
7289853 | Campbell et al. | Oct 2007 | B1 |
7289855 | Nghiem et al. | Oct 2007 | B2 |
7302294 | Kamath et al. | Nov 2007 | B2 |
7305266 | Kroll | Dec 2007 | B1 |
7310556 | Bulkes | Dec 2007 | B2 |
7319905 | Morgan et al. | Jan 2008 | B1 |
7321798 | Muhlenberg et al. | Jan 2008 | B2 |
7333853 | Mazar et al. | Feb 2008 | B2 |
7336994 | Hettrick et al. | Feb 2008 | B2 |
7347819 | Lebel et al. | Mar 2008 | B2 |
7366572 | Heruth et al. | Apr 2008 | B2 |
7373207 | Lattouf | May 2008 | B2 |
7384403 | Sherman | Jun 2008 | B2 |
7386342 | Falkenberg et al. | Jun 2008 | B1 |
7392090 | Sweeney et al. | Jun 2008 | B2 |
7406105 | DelMain et al. | Jul 2008 | B2 |
7406349 | Seeberger et al. | Jul 2008 | B2 |
7410497 | Hastings et al. | Aug 2008 | B2 |
7425200 | Brockway et al. | Sep 2008 | B2 |
7433739 | Salys et al. | Oct 2008 | B1 |
7448999 | Karicherla | Nov 2008 | B1 |
7496409 | Greenhut et al. | Feb 2009 | B2 |
7496410 | Heil | Feb 2009 | B2 |
7502652 | Gaunt et al. | Mar 2009 | B2 |
7512448 | Malick et al. | Mar 2009 | B2 |
7515969 | Tockman et al. | Apr 2009 | B2 |
7526342 | Chin et al. | Apr 2009 | B2 |
7529589 | Williams et al. | May 2009 | B2 |
7532933 | Hastings et al. | May 2009 | B2 |
7536222 | Bardy et al. | May 2009 | B2 |
7536224 | Ritscher et al. | May 2009 | B2 |
7539541 | Quiles et al. | May 2009 | B2 |
7544197 | Kelsch et al. | Jun 2009 | B2 |
7558631 | Cowan et al. | Jul 2009 | B2 |
7565195 | Kroll et al. | Jul 2009 | B1 |
7584002 | Burnes et al. | Sep 2009 | B2 |
7590455 | Heruth et al. | Sep 2009 | B2 |
7606621 | Brisken et al. | Oct 2009 | B2 |
7610088 | Chinchoy | Oct 2009 | B2 |
7610092 | Cowan et al. | Oct 2009 | B2 |
7610099 | Almendinger et al. | Oct 2009 | B2 |
7610104 | Kaplan et al. | Oct 2009 | B2 |
7616991 | Mann et al. | Nov 2009 | B2 |
7617001 | Penner et al. | Nov 2009 | B2 |
7617007 | Williams et al. | Nov 2009 | B2 |
7630767 | Poore et al. | Dec 2009 | B1 |
7634313 | Kroll et al. | Dec 2009 | B1 |
7637867 | Zdeblick | Dec 2009 | B2 |
7640060 | Zdeblick | Dec 2009 | B2 |
7647109 | Hastings et al. | Jan 2010 | B2 |
7650186 | Hastings et al. | Jan 2010 | B2 |
7657311 | Bardy et al. | Feb 2010 | B2 |
7668596 | Von Arx et al. | Feb 2010 | B2 |
7682316 | Anderson et al. | Mar 2010 | B2 |
7691047 | Ferrari | Apr 2010 | B2 |
7702392 | Echt et al. | Apr 2010 | B2 |
7713194 | Zdeblick | May 2010 | B2 |
7713195 | Zdeblick | May 2010 | B2 |
7729783 | Michels et al. | Jun 2010 | B2 |
7734333 | Ghanem et al. | Jun 2010 | B2 |
7734343 | Ransbury et al. | Jun 2010 | B2 |
7738958 | Zdeblick et al. | Jun 2010 | B2 |
7738964 | Von Arx et al. | Jun 2010 | B2 |
7742812 | Ghanem et al. | Jun 2010 | B2 |
7742816 | Masoud et al. | Jun 2010 | B2 |
7742822 | Masoud et al. | Jun 2010 | B2 |
7743151 | Vallapureddy et al. | Jun 2010 | B2 |
7747335 | Williams | Jun 2010 | B2 |
7751881 | Cowan et al. | Jul 2010 | B2 |
7758521 | Morris et al. | Jul 2010 | B2 |
7761150 | Ghanem et al. | Jul 2010 | B2 |
7761164 | Verhoef et al. | Jul 2010 | B2 |
7765001 | Echt et al. | Jul 2010 | B2 |
7769452 | Ghanem et al. | Aug 2010 | B2 |
7783362 | Whitehurst et al. | Aug 2010 | B2 |
7792588 | Harding | Sep 2010 | B2 |
7797059 | Bornzin et al. | Sep 2010 | B1 |
7801596 | Fischell et al. | Sep 2010 | B2 |
7809438 | Echt et al. | Oct 2010 | B2 |
7840281 | Kveen et al. | Nov 2010 | B2 |
7844331 | Li et al. | Nov 2010 | B2 |
7844348 | Swoyer et al. | Nov 2010 | B2 |
7846088 | Ness | Dec 2010 | B2 |
7848815 | Brisken et al. | Dec 2010 | B2 |
7848823 | Drasler et al. | Dec 2010 | B2 |
7860455 | Fukumoto et al. | Dec 2010 | B2 |
7871433 | Lattouf | Jan 2011 | B2 |
7877136 | Moffitt et al. | Jan 2011 | B1 |
7877142 | Moaddeb et al. | Jan 2011 | B2 |
7881786 | Jackson | Feb 2011 | B2 |
7881798 | Miesel et al. | Feb 2011 | B2 |
7881810 | Chitre et al. | Feb 2011 | B1 |
7890173 | Brisken et al. | Feb 2011 | B2 |
7890181 | Denzene et al. | Feb 2011 | B2 |
7890192 | Kelsch et al. | Feb 2011 | B1 |
7894885 | Bartal et al. | Feb 2011 | B2 |
7894894 | Stadler et al. | Feb 2011 | B2 |
7894907 | Cowan et al. | Feb 2011 | B2 |
7894910 | Cowan et al. | Feb 2011 | B2 |
7894915 | Chitre et al. | Feb 2011 | B1 |
7899537 | Kroll et al. | Mar 2011 | B1 |
7899541 | Cowan et al. | Mar 2011 | B2 |
7899542 | Cowan et al. | Mar 2011 | B2 |
7899554 | Williams et al. | Mar 2011 | B2 |
7901360 | Yang et al. | Mar 2011 | B1 |
7904170 | Harding | Mar 2011 | B2 |
7907993 | Ghanem et al. | Mar 2011 | B2 |
7920928 | Yang et al. | Apr 2011 | B1 |
7925343 | Min et al. | Apr 2011 | B1 |
7930022 | Zhang et al. | Apr 2011 | B2 |
7930040 | Kelsch et al. | Apr 2011 | B1 |
7937135 | Ghanem et al. | May 2011 | B2 |
7937148 | Jacobson | May 2011 | B2 |
7937161 | Hastings et al. | May 2011 | B2 |
7941214 | Kleckner et al. | May 2011 | B2 |
7945333 | Jacobson | May 2011 | B2 |
7946997 | Hübinette | May 2011 | B2 |
7949404 | Hill | May 2011 | B2 |
7949405 | Feher | May 2011 | B2 |
7953486 | Daum et al. | May 2011 | B2 |
7953493 | Fowler et al. | May 2011 | B2 |
7962202 | Bhunia | Jun 2011 | B2 |
7974702 | Fain et al. | Jul 2011 | B1 |
7979136 | Young et al. | Jul 2011 | B2 |
7983753 | Severin | Jul 2011 | B2 |
7991467 | Markowitz et al. | Aug 2011 | B2 |
7991471 | Ghanem et al. | Aug 2011 | B2 |
7996087 | Cowan et al. | Aug 2011 | B2 |
8000791 | Sunagawa et al. | Aug 2011 | B2 |
8000807 | Morris et al. | Aug 2011 | B2 |
8001975 | DiSilvestro et al. | Aug 2011 | B2 |
8002700 | Ferek-Petric et al. | Aug 2011 | B2 |
8010209 | Jacobson | Aug 2011 | B2 |
8019419 | Panescu et al. | Sep 2011 | B1 |
8019434 | Quiles et al. | Sep 2011 | B2 |
8027727 | Freeberg | Sep 2011 | B2 |
8027729 | Sunagawa et al. | Sep 2011 | B2 |
8032219 | Neumann et al. | Oct 2011 | B2 |
8036743 | Savage et al. | Oct 2011 | B2 |
8046079 | Bange et al. | Oct 2011 | B2 |
8046080 | Von Arx et al. | Oct 2011 | B2 |
8050297 | Delmain et al. | Nov 2011 | B2 |
8050759 | Stegemann et al. | Nov 2011 | B2 |
8050774 | Kveen et al. | Nov 2011 | B2 |
8055345 | Li et al. | Nov 2011 | B2 |
8055350 | Roberts | Nov 2011 | B2 |
8060212 | Rios et al. | Nov 2011 | B1 |
8065018 | Haubrich et al. | Nov 2011 | B2 |
8073542 | Doerr | Dec 2011 | B2 |
8078278 | Penner | Dec 2011 | B2 |
8078283 | Cowan et al. | Dec 2011 | B2 |
8095123 | Gray | Jan 2012 | B2 |
8102789 | Rosar et al. | Jan 2012 | B2 |
8103359 | Reddy | Jan 2012 | B2 |
8103361 | Moser | Jan 2012 | B2 |
8112148 | Giftakis et al. | Feb 2012 | B2 |
8114021 | Robertson et al. | Feb 2012 | B2 |
8121680 | Falkenberg et al. | Feb 2012 | B2 |
8123684 | Zdeblick | Feb 2012 | B2 |
8126545 | Flach et al. | Feb 2012 | B2 |
8131334 | Lu et al. | Mar 2012 | B2 |
8140161 | Willerton et al. | Mar 2012 | B2 |
8150521 | Crowley et al. | Apr 2012 | B2 |
8160672 | Kim et al. | Apr 2012 | B2 |
8160702 | Mann et al. | Apr 2012 | B2 |
8160704 | Freeberg | Apr 2012 | B2 |
8165694 | Carbanaru et al. | Apr 2012 | B2 |
8175715 | Cox | May 2012 | B1 |
8180451 | Hickman et al. | May 2012 | B2 |
8185213 | Kveen et al. | May 2012 | B2 |
8187161 | Li et al. | May 2012 | B2 |
8195293 | Limousin et al. | Jun 2012 | B2 |
8204595 | Pianca et al. | Jun 2012 | B2 |
8204605 | Hastings et al. | Jun 2012 | B2 |
8209014 | Doerr | Jun 2012 | B2 |
8214043 | Matos | Jul 2012 | B2 |
8224244 | Kim et al. | Jul 2012 | B2 |
8229556 | Li | Jul 2012 | B2 |
8233985 | Bulkes et al. | Jul 2012 | B2 |
8265748 | Liu et al. | Sep 2012 | B2 |
8265757 | Mass et al. | Sep 2012 | B2 |
8262578 | Bharmi et al. | Oct 2012 | B1 |
8280521 | Haubrich et al. | Oct 2012 | B2 |
8285387 | Utsi et al. | Oct 2012 | B2 |
8290598 | Boon et al. | Oct 2012 | B2 |
8290600 | Hastings et al. | Oct 2012 | B2 |
8295939 | Jacobson | Oct 2012 | B2 |
8301254 | Mosesov et al. | Oct 2012 | B2 |
8315701 | Cowan et al. | Nov 2012 | B2 |
8315708 | Berthelsdorf et al. | Nov 2012 | B2 |
8321021 | Kisker et al. | Nov 2012 | B2 |
8321036 | Brockway et al. | Nov 2012 | B2 |
8332036 | Hastings et al. | Dec 2012 | B2 |
8335563 | Stessman | Dec 2012 | B2 |
8335568 | Heruth et al. | Dec 2012 | B2 |
8340750 | Prakash et al. | Dec 2012 | B2 |
8340780 | Hastings et al. | Dec 2012 | B2 |
8352025 | Jacobson | Jan 2013 | B2 |
8352028 | Wenger | Jan 2013 | B2 |
8352038 | Mao et al. | Jan 2013 | B2 |
8359098 | Lund et al. | Jan 2013 | B2 |
8364261 | Stubbs et al. | Jan 2013 | B2 |
8364276 | Willis | Jan 2013 | B2 |
8369959 | Meskens | Feb 2013 | B2 |
8369962 | Abrahamson | Feb 2013 | B2 |
8380320 | Spital | Feb 2013 | B2 |
8386051 | Rys | Feb 2013 | B2 |
8391981 | Mosesov | Mar 2013 | B2 |
8391990 | Smith et al. | Mar 2013 | B2 |
8406874 | Liu et al. | Mar 2013 | B2 |
8406879 | Shuros et al. | Mar 2013 | B2 |
8406886 | Gaunt et al. | Mar 2013 | B2 |
8412352 | Griswold et al. | Apr 2013 | B2 |
8417340 | Goossen | Apr 2013 | B2 |
8417341 | Freeberg | Apr 2013 | B2 |
8423149 | Hennig | Apr 2013 | B2 |
8428722 | Verhoef et al. | Apr 2013 | B2 |
8433402 | Ruben et al. | Apr 2013 | B2 |
8433409 | Johnson et al. | Apr 2013 | B2 |
8433420 | Bange et al. | Apr 2013 | B2 |
8447412 | Dal Molin et al. | May 2013 | B2 |
8452413 | Young et al. | May 2013 | B2 |
8457740 | Osche | Jun 2013 | B2 |
8457742 | Jacobson | Jun 2013 | B2 |
8457744 | Janzig et al. | Jun 2013 | B2 |
8457761 | Wariar | Jun 2013 | B2 |
8478407 | Demmer et al. | Jul 2013 | B2 |
8478408 | Hastings et al. | Jul 2013 | B2 |
8478431 | Griswold et al. | Jul 2013 | B2 |
8494632 | Sun et al. | Jul 2013 | B2 |
8504156 | Bonner et al. | Aug 2013 | B2 |
8509910 | Sowder et al. | Aug 2013 | B2 |
8515559 | Roberts et al. | Aug 2013 | B2 |
8525340 | Eckhardt et al. | Sep 2013 | B2 |
8527068 | Ostroff | Sep 2013 | B2 |
8532790 | Griswold | Sep 2013 | B2 |
8538526 | Stahmann et al. | Sep 2013 | B2 |
8541131 | Lund et al. | Sep 2013 | B2 |
8543205 | Ostroff | Sep 2013 | B2 |
8547248 | Zdeblick et al. | Oct 2013 | B2 |
8548605 | Ollivier | Oct 2013 | B2 |
8554333 | Wu et al. | Oct 2013 | B2 |
8565882 | Matos | Oct 2013 | B2 |
8565897 | Regnier et al. | Oct 2013 | B2 |
8571678 | Wang | Oct 2013 | B2 |
8577327 | Makdissi et al. | Nov 2013 | B2 |
8588926 | Moore et al. | Nov 2013 | B2 |
8612002 | Faltys et al. | Dec 2013 | B2 |
8615310 | Khairkhahan et al. | Dec 2013 | B2 |
8626280 | Allavatam et al. | Jan 2014 | B2 |
8626294 | Sheldon et al. | Jan 2014 | B2 |
8634908 | Cowan | Jan 2014 | B2 |
8634912 | Bornzin et al. | Jan 2014 | B2 |
8634919 | Hou et al. | Jan 2014 | B1 |
8639335 | Peichel et al. | Jan 2014 | B2 |
8644934 | Hastings et al. | Feb 2014 | B2 |
8649859 | Smith et al. | Feb 2014 | B2 |
8670842 | Bornzin et al. | Mar 2014 | B1 |
8676319 | Knoll | Mar 2014 | B2 |
8676335 | Katoozi et al. | Mar 2014 | B2 |
8700173 | Edlund | Apr 2014 | B2 |
8700181 | Bornzin et al. | Apr 2014 | B2 |
8705599 | dal Molin et al. | Apr 2014 | B2 |
8718766 | Wahlberg | May 2014 | B2 |
8718773 | Willis et al. | May 2014 | B2 |
8725260 | Shuros et al. | May 2014 | B2 |
8738133 | Shuros et al. | May 2014 | B2 |
8738147 | Hastings et al. | May 2014 | B2 |
8744555 | Allavatam et al. | Jun 2014 | B2 |
8744572 | Greenhut et al. | Jun 2014 | B1 |
8747314 | Stahmann et al. | Jun 2014 | B2 |
8755884 | Demmer et al. | Jun 2014 | B2 |
8758365 | Bonner et al. | Jun 2014 | B2 |
8768483 | Schmitt et al. | Jul 2014 | B2 |
8774572 | Hamamoto | Jul 2014 | B2 |
8781605 | Bornzin et al. | Jul 2014 | B2 |
8788035 | Jacobson | Jul 2014 | B2 |
8788053 | Jacobson | Jul 2014 | B2 |
8798740 | Samade et al. | Aug 2014 | B2 |
8798745 | Jacobson | Aug 2014 | B2 |
8798762 | Fain et al. | Aug 2014 | B2 |
8798770 | Reddy | Aug 2014 | B2 |
8805505 | Roberts | Aug 2014 | B1 |
8805528 | Corndort | Aug 2014 | B2 |
8812109 | Blomqvist et al. | Aug 2014 | B2 |
8818504 | Bodner et al. | Aug 2014 | B2 |
8827913 | Havel et al. | Sep 2014 | B2 |
8831747 | Min et al. | Sep 2014 | B1 |
8855789 | Jacobson | Oct 2014 | B2 |
8868186 | Kroll | Oct 2014 | B2 |
8886339 | Faltys et al. | Nov 2014 | B2 |
8903473 | Rogers et al. | Dec 2014 | B2 |
8903500 | Smith et al. | Dec 2014 | B2 |
8903513 | Ollivier | Dec 2014 | B2 |
8909336 | Navarro-Paredes et al. | Dec 2014 | B2 |
8914131 | Bornzin et al. | Dec 2014 | B2 |
8923795 | Makdissi et al. | Dec 2014 | B2 |
8923963 | Bonner et al. | Dec 2014 | B2 |
8938300 | Rosero | Jan 2015 | B2 |
8942806 | Sheldon et al. | Jan 2015 | B2 |
8958892 | Khairkhahan et al. | Feb 2015 | B2 |
8977358 | Ewert et al. | Mar 2015 | B2 |
8989873 | Locsin | Mar 2015 | B2 |
8996109 | Karst et al. | Mar 2015 | B2 |
9002467 | Smith et al. | Apr 2015 | B2 |
9008776 | Cowan et al. | Apr 2015 | B2 |
9008777 | Dianaty et al. | Apr 2015 | B2 |
9014818 | Deterre et al. | Apr 2015 | B2 |
9017341 | Bornzin et al. | Apr 2015 | B2 |
9020611 | Khairkhahan et al. | Apr 2015 | B2 |
9037262 | Regnier et al. | May 2015 | B2 |
9042984 | Demmer et al. | May 2015 | B2 |
9072911 | Hastings et al. | Jul 2015 | B2 |
9072913 | Jacobson | Jul 2015 | B2 |
9155882 | Grubac et al. | Oct 2015 | B2 |
9168372 | Fain | Oct 2015 | B2 |
9168380 | Greenhut et al. | Oct 2015 | B1 |
9168383 | Jacobson et al. | Oct 2015 | B2 |
9180285 | Moore et al. | Nov 2015 | B2 |
9192774 | Jacobson | Nov 2015 | B2 |
9205225 | Khairkhahan et al. | Dec 2015 | B2 |
9216285 | Boling et al. | Dec 2015 | B1 |
9216293 | Berthiaume et al. | Dec 2015 | B2 |
9216298 | Jacobson | Dec 2015 | B2 |
9227077 | Jacobson | Jan 2016 | B2 |
9238145 | Wenzel et al. | Jan 2016 | B2 |
9242102 | Khairkhahan et al. | Jan 2016 | B2 |
9242113 | Smith et al. | Jan 2016 | B2 |
9248300 | Rys et al. | Feb 2016 | B2 |
9265436 | Min et al. | Feb 2016 | B2 |
9265962 | Dianaty et al. | Feb 2016 | B2 |
9272155 | Ostroff | Mar 2016 | B2 |
9278218 | Karst et al. | Mar 2016 | B2 |
9278229 | Reinke et al. | Mar 2016 | B1 |
9283381 | Grubac et al. | Mar 2016 | B2 |
9283382 | Berthiaume et al. | Mar 2016 | B2 |
9289612 | Sambelashvili et al. | Mar 2016 | B1 |
9302115 | Molin et al. | Apr 2016 | B2 |
9333364 | Echt et al. | May 2016 | B2 |
9358387 | Suwito et al. | Jun 2016 | B2 |
9358400 | Jacobson | Jun 2016 | B2 |
9364675 | Deterre et al. | Jun 2016 | B2 |
9370663 | Moulder | Jun 2016 | B2 |
9375580 | Bonner et al. | Jun 2016 | B2 |
9375581 | Baru et al. | Jun 2016 | B2 |
9381365 | Kibler et al. | Jul 2016 | B2 |
9393424 | Demmer et al. | Jul 2016 | B2 |
9393436 | Doerr | Jul 2016 | B2 |
9399139 | Demmer et al. | Jul 2016 | B2 |
9399140 | Cho et al. | Jul 2016 | B2 |
9409033 | Jacobson | Aug 2016 | B2 |
9427594 | Bornzin et al. | Aug 2016 | B1 |
9433368 | Stahmann et al. | Sep 2016 | B2 |
9433780 | Régnier et al. | Sep 2016 | B2 |
9457193 | Klimovitch et al. | Oct 2016 | B2 |
9492668 | Sheldon et al. | Nov 2016 | B2 |
9492669 | Demmer et al. | Nov 2016 | B2 |
9492674 | Schmidt et al. | Nov 2016 | B2 |
9492677 | Greenhut et al. | Nov 2016 | B2 |
9511233 | Sambelashvili | Dec 2016 | B2 |
9511236 | Varady et al. | Dec 2016 | B2 |
9511237 | Deterre et al. | Dec 2016 | B2 |
9522276 | Shen et al. | Dec 2016 | B2 |
9522280 | Fishler et al. | Dec 2016 | B2 |
9526522 | Wood et al. | Dec 2016 | B2 |
9526891 | Eggen et al. | Dec 2016 | B2 |
9526909 | Stahmann et al. | Dec 2016 | B2 |
9533163 | Klimovitch et al. | Jan 2017 | B2 |
9561382 | Persson et al. | Feb 2017 | B2 |
9566012 | Greenhut et al. | Feb 2017 | B2 |
9636511 | Carney et al. | May 2017 | B2 |
20020032470 | Linberg | Mar 2002 | A1 |
20020035376 | Bardy et al. | Mar 2002 | A1 |
20020035377 | Bardy et al. | Mar 2002 | A1 |
20020035378 | Bardy et al. | Mar 2002 | A1 |
20020035380 | Rissmann et al. | Mar 2002 | A1 |
20020035381 | Bardy et al. | Mar 2002 | A1 |
20020042629 | Bardy et al. | Apr 2002 | A1 |
20020042630 | Bardy et al. | Apr 2002 | A1 |
20020042634 | Bardy et al. | Apr 2002 | A1 |
20020049475 | Bardy et al. | Apr 2002 | A1 |
20020052636 | Bardy et al. | May 2002 | A1 |
20020068958 | Bardy et al. | Jun 2002 | A1 |
20020072773 | Bardy et al. | Jun 2002 | A1 |
20020082665 | Haller et al. | Jun 2002 | A1 |
20020091414 | Bardy et al. | Jul 2002 | A1 |
20020095196 | Linberg | Jul 2002 | A1 |
20020099423 | Berg et al. | Jul 2002 | A1 |
20020103510 | Bardy et al. | Aug 2002 | A1 |
20020107545 | Rissmann et al. | Aug 2002 | A1 |
20020107546 | Ostroff et al. | Aug 2002 | A1 |
20020107547 | Erlinger et al. | Aug 2002 | A1 |
20020107548 | Bardy et al. | Aug 2002 | A1 |
20020107549 | Bardy et al. | Aug 2002 | A1 |
20020107559 | Sanders et al. | Aug 2002 | A1 |
20020120299 | Ostroff et al. | Aug 2002 | A1 |
20020173830 | Starkweather et al. | Nov 2002 | A1 |
20020193846 | Pool et al. | Dec 2002 | A1 |
20030009203 | Lebel et al. | Jan 2003 | A1 |
20030028082 | Thompson | Feb 2003 | A1 |
20030040779 | Engmark et al. | Feb 2003 | A1 |
20030041866 | Linberg et al. | Mar 2003 | A1 |
20030045805 | Sheldon et al. | Mar 2003 | A1 |
20030088278 | Bardy et al. | May 2003 | A1 |
20030097153 | Bardy et al. | May 2003 | A1 |
20030105497 | Zhu et al. | Jun 2003 | A1 |
20030114908 | Flach | Jun 2003 | A1 |
20030144701 | Mehra et al. | Jul 2003 | A1 |
20030187460 | Chin et al. | Oct 2003 | A1 |
20030187461 | Chin | Oct 2003 | A1 |
20040024435 | Leckrone et al. | Feb 2004 | A1 |
20040068302 | Rodgers et al. | Apr 2004 | A1 |
20040087938 | Leckrone et al. | May 2004 | A1 |
20040088035 | Guenst et al. | May 2004 | A1 |
20040102830 | Williams | May 2004 | A1 |
20040127959 | Amundson et al. | Jul 2004 | A1 |
20040133242 | Chapman et al. | Jul 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040147973 | Hauser | Jul 2004 | A1 |
20040167558 | Igo et al. | Aug 2004 | A1 |
20040167587 | Thompson | Aug 2004 | A1 |
20040172071 | Bardy et al. | Sep 2004 | A1 |
20040172077 | Chinchoy | Sep 2004 | A1 |
20040172104 | Berg et al. | Sep 2004 | A1 |
20040176817 | Wahlstrand et al. | Sep 2004 | A1 |
20040176818 | Wahlstrand et al. | Sep 2004 | A1 |
20040176830 | Fang | Sep 2004 | A1 |
20040186529 | Bardy et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040210292 | Bardy et al. | Oct 2004 | A1 |
20040210293 | Bardy et al. | Oct 2004 | A1 |
20040210294 | Bardy et al. | Oct 2004 | A1 |
20040215308 | Bardy et al. | Oct 2004 | A1 |
20040220624 | Ritscher et al. | Nov 2004 | A1 |
20040220626 | Wagner | Nov 2004 | A1 |
20040220639 | Mulligan et al. | Nov 2004 | A1 |
20040230283 | Prinzen et al. | Nov 2004 | A1 |
20040249431 | Ransbury et al. | Dec 2004 | A1 |
20040260348 | Bakken et al. | Dec 2004 | A1 |
20040267303 | Guenst | Dec 2004 | A1 |
20050061320 | Lee et al. | Mar 2005 | A1 |
20050070962 | Echt et al. | Mar 2005 | A1 |
20050102003 | Grabek et al. | May 2005 | A1 |
20050149138 | Min et al. | Jul 2005 | A1 |
20050165466 | Morris et al. | Jul 2005 | A1 |
20050182465 | Ness | Aug 2005 | A1 |
20050203410 | Jenkins | Sep 2005 | A1 |
20050283208 | Von Arx et al. | Dec 2005 | A1 |
20050288743 | Ahn et al. | Dec 2005 | A1 |
20060042830 | Maghribi et al. | Mar 2006 | A1 |
20060052829 | Sun et al. | Mar 2006 | A1 |
20060052830 | Spinelli et al. | Mar 2006 | A1 |
20060064135 | Brockway | Mar 2006 | A1 |
20060064149 | Belacazar et al. | Mar 2006 | A1 |
20060085039 | Hastings et al. | Apr 2006 | A1 |
20060085041 | Hastings et al. | Apr 2006 | A1 |
20060085042 | Hastings et al. | Apr 2006 | A1 |
20060095078 | Tronnes | May 2006 | A1 |
20060106442 | Richardson et al. | May 2006 | A1 |
20060116746 | Chin | Jun 2006 | A1 |
20060135999 | Bodner et al. | Jun 2006 | A1 |
20060136004 | Cowan et al. | Jun 2006 | A1 |
20060161061 | Echt et al. | Jul 2006 | A1 |
20060200002 | Guenst | Sep 2006 | A1 |
20060206151 | Lu | Sep 2006 | A1 |
20060212079 | Routh et al. | Sep 2006 | A1 |
20060241701 | Markowitz et al. | Oct 2006 | A1 |
20060241705 | Neumann et al. | Oct 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20060259088 | Pastore et al. | Nov 2006 | A1 |
20060265018 | Smith et al. | Nov 2006 | A1 |
20070004979 | Wojciechowicz et al. | Jan 2007 | A1 |
20070016098 | Kim et al. | Jan 2007 | A1 |
20070027508 | Cowan | Feb 2007 | A1 |
20070078490 | Cowan et al. | Apr 2007 | A1 |
20070088394 | Jacobson | Apr 2007 | A1 |
20070088396 | Jacobson | Apr 2007 | A1 |
20070088397 | Jacobson | Apr 2007 | A1 |
20070088398 | Jacobson | Apr 2007 | A1 |
20070088405 | Jacobson | Apr 2007 | A1 |
20070135882 | Drasler et al. | Jun 2007 | A1 |
20070135883 | Drasler et al. | Jun 2007 | A1 |
20070150037 | Hastings et al. | Jun 2007 | A1 |
20070150038 | Hastings et al. | Jun 2007 | A1 |
20070156190 | Cinbis | Jul 2007 | A1 |
20070219525 | Gelfand et al. | Sep 2007 | A1 |
20070219590 | Hastings et al. | Sep 2007 | A1 |
20070225545 | Ferrari | Sep 2007 | A1 |
20070233206 | Frikart et al. | Oct 2007 | A1 |
20070239244 | Morgan et al. | Oct 2007 | A1 |
20070255376 | Michels et al. | Nov 2007 | A1 |
20070276444 | Gelbart et al. | Nov 2007 | A1 |
20070293900 | Sheldon et al. | Dec 2007 | A1 |
20070293904 | Gelbart et al. | Dec 2007 | A1 |
20080004663 | Jorgenson | Jan 2008 | A1 |
20080021505 | Hastings et al. | Jan 2008 | A1 |
20080021519 | De Geest et al. | Jan 2008 | A1 |
20080021532 | Kveen et al. | Jan 2008 | A1 |
20080065183 | Whitehurst et al. | Mar 2008 | A1 |
20080065185 | Worley | Mar 2008 | A1 |
20080071318 | Brooke et al. | Mar 2008 | A1 |
20080109054 | Hastings et al. | May 2008 | A1 |
20080119911 | Rosero | May 2008 | A1 |
20080130670 | Kim et al. | Jun 2008 | A1 |
20080154139 | Shuros et al. | Jun 2008 | A1 |
20080154322 | Jackson et al. | Jun 2008 | A1 |
20080228234 | Stancer | Sep 2008 | A1 |
20080234771 | Chinchoy et al. | Sep 2008 | A1 |
20080243217 | Wildon | Oct 2008 | A1 |
20080269814 | Rosero | Oct 2008 | A1 |
20080269825 | Chinchoy et al. | Oct 2008 | A1 |
20080275518 | Ghanem et al. | Nov 2008 | A1 |
20080275519 | Ghanem et al. | Nov 2008 | A1 |
20080288039 | Reddy | Nov 2008 | A1 |
20080294208 | Willis et al. | Nov 2008 | A1 |
20080294210 | Rosero | Nov 2008 | A1 |
20080294229 | Friedman et al. | Nov 2008 | A1 |
20080306359 | Zdeblick et al. | Dec 2008 | A1 |
20090018599 | Hastings et al. | Jan 2009 | A1 |
20090024180 | Kisker et al. | Jan 2009 | A1 |
20090036941 | Corbucci | Feb 2009 | A1 |
20090048646 | Katoozi et al. | Feb 2009 | A1 |
20090062895 | Stahmann et al. | Mar 2009 | A1 |
20090082827 | Kveen et al. | Mar 2009 | A1 |
20090082828 | Ostroff | Mar 2009 | A1 |
20090088813 | Brockway et al. | Apr 2009 | A1 |
20090131907 | Chin et al. | May 2009 | A1 |
20090135886 | Robertson et al. | May 2009 | A1 |
20090143835 | Pastore et al. | Jun 2009 | A1 |
20090171408 | Solem | Jul 2009 | A1 |
20090171414 | Kelly et al. | Jul 2009 | A1 |
20090204163 | Shuros et al. | Aug 2009 | A1 |
20090204170 | Hastings et al. | Aug 2009 | A1 |
20090210024 | M | Aug 2009 | A1 |
20090216292 | Pless et al. | Aug 2009 | A1 |
20090234407 | Hastings et al. | Sep 2009 | A1 |
20090234411 | Sambelashvili et al. | Sep 2009 | A1 |
20090266573 | Engmark et al. | Oct 2009 | A1 |
20090275998 | Bumes et al. | Nov 2009 | A1 |
20090275999 | Burnes et al. | Nov 2009 | A1 |
20090299447 | Jensen et al. | Dec 2009 | A1 |
20100013668 | Kantervik | Jan 2010 | A1 |
20100016911 | Willis et al. | Jan 2010 | A1 |
20100023085 | Wu et al. | Jan 2010 | A1 |
20100030061 | Canfield et al. | Feb 2010 | A1 |
20100030327 | Chatel | Feb 2010 | A1 |
20100042108 | Hibino | Feb 2010 | A1 |
20100056871 | Govari et al. | Mar 2010 | A1 |
20100063375 | Kassab et al. | Mar 2010 | A1 |
20100063562 | Cowan et al. | Mar 2010 | A1 |
20100069983 | Peacock, III | Mar 2010 | A1 |
20100094367 | Sen | Apr 2010 | A1 |
20100114209 | Krause et al. | May 2010 | A1 |
20100114214 | Morelli et al. | May 2010 | A1 |
20100125281 | Jacobson et al. | May 2010 | A1 |
20100168761 | Kassab et al. | Jul 2010 | A1 |
20100168819 | Freeberg | Jul 2010 | A1 |
20100198288 | Ostroff | Aug 2010 | A1 |
20100198304 | Wang | Aug 2010 | A1 |
20100217367 | Belson | Aug 2010 | A1 |
20100228308 | Cowan et al. | Sep 2010 | A1 |
20100234906 | Koh | Sep 2010 | A1 |
20100234924 | Willis | Sep 2010 | A1 |
20100241185 | Mahapatra et al. | Sep 2010 | A1 |
20100249729 | Morris et al. | Sep 2010 | A1 |
20100286744 | Echt et al. | Nov 2010 | A1 |
20100298841 | Prinzen et al. | Nov 2010 | A1 |
20100312309 | Harding | Dec 2010 | A1 |
20110022113 | Zdeblick et al. | Jan 2011 | A1 |
20110071586 | Jacobson | Mar 2011 | A1 |
20110077708 | Ostroff | Mar 2011 | A1 |
20110112600 | Cowan et al. | May 2011 | A1 |
20110118588 | Komblau et al. | May 2011 | A1 |
20110118810 | Cowan et al. | May 2011 | A1 |
20110137187 | Yang et al. | Jun 2011 | A1 |
20110144720 | Cowan et al. | Jun 2011 | A1 |
20110152970 | Jollota et al. | Jun 2011 | A1 |
20110160558 | Rassatt et al. | Jun 2011 | A1 |
20110160565 | Stubbs et al. | Jun 2011 | A1 |
20110160801 | Markowitz et al. | Jun 2011 | A1 |
20110160806 | Lyden et al. | Jun 2011 | A1 |
20110166620 | Cowan et al. | Jul 2011 | A1 |
20110166621 | Cowan et al. | Jul 2011 | A1 |
20110184491 | Kivi | Jul 2011 | A1 |
20110190835 | Brockway et al. | Aug 2011 | A1 |
20110208260 | Jacobson | Aug 2011 | A1 |
20110218587 | Jacobson | Sep 2011 | A1 |
20110230734 | Fain et al. | Sep 2011 | A1 |
20110237967 | Moore et al. | Sep 2011 | A1 |
20110245890 | Brisben et al. | Oct 2011 | A1 |
20110251660 | Griswold | Oct 2011 | A1 |
20110251662 | Griswold et al. | Oct 2011 | A1 |
20110270099 | Ruben et al. | Nov 2011 | A1 |
20110270339 | Murray, III et al. | Nov 2011 | A1 |
20110270340 | Pellegrini et al. | Nov 2011 | A1 |
20110276102 | Cohen | Nov 2011 | A1 |
20110282423 | Jacobson | Nov 2011 | A1 |
20120004527 | Thompson et al. | Jan 2012 | A1 |
20120029323 | Zhao | Feb 2012 | A1 |
20120041508 | Rousso et al. | Feb 2012 | A1 |
20120059433 | Cowan et al. | Mar 2012 | A1 |
20120059436 | Fontaine et al. | Mar 2012 | A1 |
20120065500 | Rogers et al. | Mar 2012 | A1 |
20120078322 | Dal Molin et al. | Mar 2012 | A1 |
20120089198 | Ostroff | Apr 2012 | A1 |
20120093245 | Makdissi et al. | Apr 2012 | A1 |
20120095521 | Hintz | Apr 2012 | A1 |
20120095539 | Khairkhahan et al. | Apr 2012 | A1 |
20120101540 | O'Brien et al. | Apr 2012 | A1 |
20120101553 | Reddy | Apr 2012 | A1 |
20120109148 | Bonner et al. | May 2012 | A1 |
20120109149 | Bonner et al. | May 2012 | A1 |
20120109236 | Jacobson et al. | May 2012 | A1 |
20120109259 | Bond et al. | May 2012 | A1 |
20120116489 | Khairkhahan et al. | May 2012 | A1 |
20120150251 | Giftakis et al. | Jun 2012 | A1 |
20120158111 | Khairkhahan et al. | Jun 2012 | A1 |
20120165827 | Khairkhahan et al. | Jun 2012 | A1 |
20120172690 | Anderson et al. | Jul 2012 | A1 |
20120172891 | Lee | Jul 2012 | A1 |
20120172892 | Grubac et al. | Jul 2012 | A1 |
20120172942 | Berg | Jul 2012 | A1 |
20120197350 | Roberts et al. | Aug 2012 | A1 |
20120197373 | Khairkhahan et al. | Aug 2012 | A1 |
20120215285 | Tahmasian et al. | Aug 2012 | A1 |
20120232565 | Kveen et al. | Sep 2012 | A1 |
20120245665 | Friedman et al. | Sep 2012 | A1 |
20120277600 | Greenhut | Nov 2012 | A1 |
20120277606 | Ellingson et al. | Nov 2012 | A1 |
20120283795 | Stancer et al. | Nov 2012 | A1 |
20120283807 | Deterre et al. | Nov 2012 | A1 |
20120290025 | Keimel | Nov 2012 | A1 |
20120296381 | Mates | Nov 2012 | A1 |
20120303082 | Dong et al. | Nov 2012 | A1 |
20120316613 | Keefe et al. | Dec 2012 | A1 |
20130012151 | Hankins | Jan 2013 | A1 |
20130023975 | Locsin | Jan 2013 | A1 |
20130035748 | Bonner et al. | Feb 2013 | A1 |
20130041422 | Jacobson | Feb 2013 | A1 |
20130053908 | Smith et al. | Feb 2013 | A1 |
20130053915 | Holmstrom et al. | Feb 2013 | A1 |
20130053921 | Bonner et al. | Feb 2013 | A1 |
20130060298 | Splett et al. | Mar 2013 | A1 |
20130066169 | Rys et al. | Mar 2013 | A1 |
20130072770 | Rao et al. | Mar 2013 | A1 |
20130079798 | Tran et al. | Mar 2013 | A1 |
20130079861 | Reinert et al. | Mar 2013 | A1 |
20130085350 | Schugt et al. | Apr 2013 | A1 |
20130085403 | Gunderson et al. | Apr 2013 | A1 |
20130085550 | Polefko et al. | Apr 2013 | A1 |
20130096649 | Martin et al. | Apr 2013 | A1 |
20130103047 | Steingisser et al. | Apr 2013 | A1 |
20130103109 | Jacobson | Apr 2013 | A1 |
20130110008 | Bourget et al. | May 2013 | A1 |
20130110127 | Bornzin et al. | May 2013 | A1 |
20130110192 | Tran et al. | May 2013 | A1 |
20130110219 | Bornzin et al. | May 2013 | A1 |
20130116529 | Min et al. | May 2013 | A1 |
20130116738 | Samade et al. | May 2013 | A1 |
20130116740 | Bornzin | May 2013 | A1 |
20130116741 | Bornzin et al. | May 2013 | A1 |
20130123872 | Bornzin et al. | May 2013 | A1 |
20130123875 | Varady et al. | May 2013 | A1 |
20130131591 | Berthiaume et al. | May 2013 | A1 |
20130131693 | Berthiaume et al. | May 2013 | A1 |
20130138006 | Bornzin et al. | May 2013 | A1 |
20130150695 | Biela et al. | Jun 2013 | A1 |
20130150911 | Perschbacher et al. | Jun 2013 | A1 |
20130150912 | Perschbacher et al. | Jun 2013 | A1 |
20130184776 | Shuros et al. | Jul 2013 | A1 |
20130196703 | Masoud et al. | Aug 2013 | A1 |
20130197609 | Moore et al. | Aug 2013 | A1 |
20130231710 | Jacobson | Sep 2013 | A1 |
20130238072 | Deterre et al. | Sep 2013 | A1 |
20130238073 | Makdissi et al. | Sep 2013 | A1 |
20130253342 | Griswold et al. | Sep 2013 | A1 |
20130253343 | Waldhauser et al. | Sep 2013 | A1 |
20130253344 | Griswold et al. | Sep 2013 | A1 |
20130253345 | Griswold et al. | Sep 2013 | A1 |
20130253346 | Griswold et al. | Sep 2013 | A1 |
20130253347 | Griswold et al. | Sep 2013 | A1 |
20130261497 | Pertijs et al. | Oct 2013 | A1 |
20130265144 | Banna et al. | Oct 2013 | A1 |
20130268042 | Hastings et al. | Oct 2013 | A1 |
20130274828 | Willis | Oct 2013 | A1 |
20130274847 | Ostroff | Oct 2013 | A1 |
20130282070 | Cowan et al. | Oct 2013 | A1 |
20130282073 | Cowan et al. | Oct 2013 | A1 |
20130296727 | Sullivan et al. | Nov 2013 | A1 |
20130303872 | Taff et al. | Nov 2013 | A1 |
20130324825 | Ostroff et al. | Dec 2013 | A1 |
20130325081 | Karst et al. | Dec 2013 | A1 |
20130345770 | Dianaty et al. | Dec 2013 | A1 |
20140012344 | Hastings et al. | Jan 2014 | A1 |
20140018876 | Ostroff | Jan 2014 | A1 |
20140018877 | Demmer et al. | Jan 2014 | A1 |
20140031836 | Ollivier | Jan 2014 | A1 |
20140039570 | Carroll et al. | Feb 2014 | A1 |
20140039591 | Drasler et al. | Feb 2014 | A1 |
20140043146 | Makdissi et al. | Feb 2014 | A1 |
20140046395 | Regnier et al. | Feb 2014 | A1 |
20140046420 | Moore et al. | Feb 2014 | A1 |
20140058240 | Mothilal et al. | Feb 2014 | A1 |
20140058494 | Ostroff et al. | Feb 2014 | A1 |
20140074114 | Khairkhahan et al. | Mar 2014 | A1 |
20140074186 | Faltys et al. | Mar 2014 | A1 |
20140094891 | Pare et al. | Apr 2014 | A1 |
20140100627 | Min | Apr 2014 | A1 |
20140107723 | Hou et al. | Apr 2014 | A1 |
20140121719 | Bonner et al. | May 2014 | A1 |
20140121720 | Bonner et al. | May 2014 | A1 |
20140121722 | Sheldon et al. | May 2014 | A1 |
20140128935 | Kumar et al. | May 2014 | A1 |
20140135865 | Hastings et al. | May 2014 | A1 |
20140142648 | Smith et al. | May 2014 | A1 |
20140148675 | Nordstrom et al. | May 2014 | A1 |
20140148815 | Wenzel et al. | May 2014 | A1 |
20140155950 | Hastings et al. | Jun 2014 | A1 |
20140169162 | Romano et al. | Jun 2014 | A1 |
20140172060 | Bornzin et al. | Jun 2014 | A1 |
20140180306 | Grubac et al. | Jun 2014 | A1 |
20140180366 | Edlund | Jun 2014 | A1 |
20140207149 | Hastings et al. | Jul 2014 | A1 |
20140207210 | Willis et al. | Jul 2014 | A1 |
20140214104 | Greenhut et al. | Jul 2014 | A1 |
20140222098 | Baru et al. | Aug 2014 | A1 |
20140222109 | Moulder | Aug 2014 | A1 |
20140228913 | Molin et al. | Aug 2014 | A1 |
20140236172 | Hastings et al. | Aug 2014 | A1 |
20140243848 | Auricchio et al. | Aug 2014 | A1 |
20140255298 | Cole et al. | Sep 2014 | A1 |
20140257324 | Fain | Sep 2014 | A1 |
20140257422 | Herken | Sep 2014 | A1 |
20140257444 | Cole et al. | Sep 2014 | A1 |
20140276929 | Foster et al. | Sep 2014 | A1 |
20140303704 | Suwito et al. | Oct 2014 | A1 |
20140309706 | Jacobson | Oct 2014 | A1 |
20140379041 | Foster | Dec 2014 | A1 |
20150025612 | Haasl et al. | Jan 2015 | A1 |
20150039041 | Smith et al. | Feb 2015 | A1 |
20150051609 | Schmidt et al. | Feb 2015 | A1 |
20150051610 | Schmidt et al. | Feb 2015 | A1 |
20150051611 | Schmidt et al. | Feb 2015 | A1 |
20150051612 | Schmidt et al. | Feb 2015 | A1 |
20150051613 | Schmidt et al. | Feb 2015 | A1 |
20150051614 | Schmidt et al. | Feb 2015 | A1 |
20150051615 | Schmidt et al. | Feb 2015 | A1 |
20150051616 | Haasl et al. | Feb 2015 | A1 |
20150051682 | Schmidt et al. | Feb 2015 | A1 |
20150057520 | Foster et al. | Feb 2015 | A1 |
20150057558 | Stahmann et al. | Feb 2015 | A1 |
20150057721 | Stahmann et al. | Feb 2015 | A1 |
20150088155 | Stahmann et al. | Mar 2015 | A1 |
20150105836 | Bonner et al. | Apr 2015 | A1 |
20150157861 | Aghassian | Jun 2015 | A1 |
20150173655 | Demmer et al. | Jun 2015 | A1 |
20150190638 | Smith et al. | Jul 2015 | A1 |
20150196756 | Stahmann et al. | Jul 2015 | A1 |
20150196757 | Stahmann et al. | Jul 2015 | A1 |
20150196758 | Stahmann et al. | Jul 2015 | A1 |
20150196769 | Stahmann et al. | Jul 2015 | A1 |
20150217119 | Nikolski et al. | Aug 2015 | A1 |
20150221898 | Chi et al. | Aug 2015 | A1 |
20150224315 | Stahmann | Aug 2015 | A1 |
20150224320 | Stahmann | Aug 2015 | A1 |
20150258345 | Smith et al. | Sep 2015 | A1 |
20150290468 | Zhang | Oct 2015 | A1 |
20150297905 | Greenhut et al. | Oct 2015 | A1 |
20150297907 | Zhang | Oct 2015 | A1 |
20150305637 | Greenhut et al. | Oct 2015 | A1 |
20150305638 | Zhang | Oct 2015 | A1 |
20150305639 | Greenhut et al. | Oct 2015 | A1 |
20150305640 | Reinke et al. | Oct 2015 | A1 |
20150305641 | Stadler et al. | Oct 2015 | A1 |
20150305642 | Reinke et al. | Oct 2015 | A1 |
20150306374 | Seifert et al. | Oct 2015 | A1 |
20150306375 | Marshall et al. | Oct 2015 | A1 |
20150306406 | Crutchfield et al. | Oct 2015 | A1 |
20150306407 | Crutchfield et al. | Oct 2015 | A1 |
20150306408 | Greenhut et al. | Oct 2015 | A1 |
20150321016 | O'Brien et al. | Nov 2015 | A1 |
20150328459 | Chin et al. | Nov 2015 | A1 |
20160015322 | Anderson et al. | Jan 2016 | A1 |
20160023000 | Cho et al. | Jan 2016 | A1 |
20160030757 | Jacobson | Feb 2016 | A1 |
20160033177 | Barot et al. | Feb 2016 | A1 |
20160121127 | Klimovitch et al. | May 2016 | A1 |
20160121128 | Fishler et al. | May 2016 | A1 |
20160121129 | Persson et al. | May 2016 | A1 |
20160213919 | Suwito et al. | Jul 2016 | A1 |
20160213937 | Reinke et al. | Jul 2016 | A1 |
20160213939 | Carney et al. | Jul 2016 | A1 |
20160228026 | Jackson | Aug 2016 | A1 |
20160317825 | Jacobson | Nov 2016 | A1 |
20160367823 | Cowan et al. | Dec 2016 | A1 |
20170014629 | Ghosh et al. | Jan 2017 | A1 |
20170035315 | Jackson | Feb 2017 | A1 |
20170043173 | Sharma et al. | Feb 2017 | A1 |
20170043174 | Greenhut et al. | Feb 2017 | A1 |
Number | Date | Country |
---|---|---|
2008279789 | Oct 2011 | AU |
2008329620 | May 2014 | AU |
2014203793 | Jul 2014 | AU |
1003904 | Jan 1977 | CA |
202933393 | May 2013 | CN |
0362611 | Apr 1990 | EP |
503823 | Sep 1992 | EP |
1702648 | Sep 2006 | EP |
1904166 | Jun 2011 | EP |
2433675 | Jan 2013 | EP |
2441491 | Jan 2013 | EP |
2452721 | Nov 2013 | EP |
1948296 | Jan 2014 | EP |
2662113 | Jan 2014 | EP |
2471452 | Dec 2014 | EP |
2760541 | May 2016 | EP |
2833966 | May 2016 | EP |
2000051373 | Feb 2000 | JP |
2002502640 | Jan 2002 | JP |
2004512105 | Apr 2004 | JP |
2005508208 | Mar 2005 | JP |
2005245215 | Sep 2005 | JP |
2008540040 | Nov 2008 | JP |
5199867 | Feb 2013 | JP |
9500202 | Jan 1995 | WO |
9636134 | Nov 1996 | WO |
9724981 | Jul 1997 | WO |
9826840 | Jun 1998 | WO |
9939767 | Aug 1999 | WO |
0234330 | Jan 2003 | WO |
02098282 | May 2003 | WO |
2005000206 | Apr 2005 | WO |
2005042089 | May 2005 | WO |
2006065394 | Jun 2006 | WO |
2006086435 | Aug 2006 | WO |
2006113659 | Oct 2006 | WO |
2006124833 | May 2007 | WO |
2007073435 | Jun 2007 | WO |
2007075974 | Jul 2007 | WO |
2009006531 | Jan 2009 | WO |
2012054102 | Apr 2012 | WO |
2013080038 | Jun 2013 | WO |
2013098644 | Aug 2013 | WO |
2013184787 | Dec 2013 | WO |
2014120769 | Aug 2014 | WO |
Entry |
---|
US 8,886,318 B2, 11/2014, Jacobson et al. (withdrawn) |
Asirvatham et al., “Intramyocardial Pacing and Sensing for the Enhancement of Cardiac Stimulation and Sensing Specificity,” PACE, vol. 30, pp. 748-754, Jun. 2007. |
Henz et al., “Synchronous Ventricular Pacing without Crossing the Tricuspid Valve or Entering the Coronary Sinus-Preliminary Results,” Journal of Cardiovascular Electrophysiology, vol. 20(12):1391-1397, Dec. 2009. doi: 10.1111/j.0540-8167.2009.01556.x. |
“Instructions for Use System 1, Leadless Cardiac Pacemaker (LCP) and Delivery Catheter,” Nanostim Leadless Pacemakers, pp. 1-28, 2013. |
Hachisuka et al., “Development and Performance Analysis of an Intra-Body Communication Device,” The 12th International Conference on Solid State Sensors, Actuators and Microsystems, vol. 4A1.3, pp. 1722-1725, 2003. |
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, Jan. 29, 2016, 15 pages. |
Seyedi et al., “A Survey on Intrabody Communications for Body Area Network Application,” IEEE Transactions on Biomedical Engineering,vol. 60(8): 2067-2079, 2013. |
Spickler et al., “Totally Self-Contained Intracardiac Pacemaker,” Journal of Electrocardiology, vol. 3(384): 324-331, 1970. |
Wegmüller, “Intra-Body Communication for Biomedical Sensor Networks,” Diss. ETH, No. 17323, 1-173, 2007. |
Number | Date | Country | |
---|---|---|---|
20170182327 A1 | Jun 2017 | US |
Number | Date | Country | |
---|---|---|---|
62271647 | Dec 2015 | US |